rfhg_5584.1

Basic information about the TSS

---

TSS ID: rfhg_5584.1 Species: human Chr: chr1		Start: 40040220 End: 40040257 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2154957,EH38E1339914)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000372797.7:0 ENST00000372802.5:0 GeneID: 10487 HGNC/MGI_ID: HGNC:20040 UniProt_ID: Q01518 Nearer transcript ids and distances: ENST00000449311.5:66 LF206602:270 MA442179:270 ENST00000421589.5:326 HM005631:326 AK315731:424 ENST00000414893.5:463 ENST00000372792.7:472 ENST00000372805.8:472 NM_001350485.2:472 NM_001105530.2:472 NM_001350483.2:472 NM_001350476.2:472 NM_001350475.2:472 NM_001330502.2:472 NM_006367.4:472 NM_001350482.2:472 NM_001350477.3:472 NM_001350484.2:472 NM_001350478.2:472 AK297829:473 AK300861:473 AK096193:474 ENST00000414281.5:475 ENST00000420216.5:476 AK222513:485 BC095440:486 ENST00000372798.5:495 AK295396:495 AK298110:495 ENST00000340450.7:496 M98474:499 view more...

Gene_name: cyclase associated actin cytoskeleton regulatory protein 1 Gene_symbol: CAP1 Gene_synonyms: CAP Gene_source: HGNC:20040

TATA-Box annotation

---

Distance to TSS:	173
Nearest PromoterID:	NM_001350479
Entrez ID:	10487
Nearest Unigene:	Hs.370581
Nearest Refseq:	NM_006367
Nearest Ensembl:	ENSG00000131236
Gene Name:	cyclase associated actin cytoskeleton regulatory protein 1
Gene Alias:	CAP|CAP1-PEN
Gene Type:	protein-coding
CpG%:	0.108108
GC%:	0.710526
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CAP1 p2@CAP1 p3@CAP1 p4@CAP1 p5@CAP1 p6@CAP1 p9@CAP1 p10@CAP1
Sample		p1@CAP1	p2@CAP1	p3@CAP1	p4@CAP1	p5@CAP1	p6@CAP1	p9@CAP1	p10@CAP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	56.49	0.58	0.97	0.39	0.19	0.19	0.97	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	61.10	0.20	0.61	1.21	0.81	0.00	0.61	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	66.36	0.58	0.77	0.39	0.19	0.19	0.58	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	46.16	0.00	1.46	0.21	0.62	0.21	0.62	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	52.19	0.45	0.67	0.22	0.45	0.00	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	54.65	0.58	0.39	0.19	0.39	0.00	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	63.62	0.22	1.74	0.65	1.09	0.00	1.09	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	55.95	0.48	1.94	0.00	0.48	0.00	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	51.93	0.85	0.43	0.21	0.21	0.00	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	31.30	0.00	0.00	0.58	0.00	0.00	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	29.51	0.00	0.00	0.00	0.40	0.00	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.39	0.00	0.00	0.41	0.81	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	73.99	0.97	0.48	0.32	0.48	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	85.85	0.30	1.50	0.30	0.75	0.15	0.15	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	76.62	0.22	0.66	0.44	0.66	0.00	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	67.40	0.50	0.50	0.25	1.26	0.75	0.25	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	73.17	0.87	0.66	0.87	0.44	0.22	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	65.80	0.42	1.27	0.42	0.00	1.27	0.42	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	59.18	0.53	0.00	0.00	0.00	0.53	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	67.70	1.05	0.60	0.30	0.60	0.15	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	83.67	1.34	0.40	0.53	0.27	0.27	0.53	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	76.13	0.52	0.86	0.69	0.52	0.35	0.17	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	80.66	0.78	0.52	0.26	0.39	0.39	0.26	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	70.62	0.73	1.70	0.97	0.24	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	67.59	0.77	0.77	0.26	0.77	0.52	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	62.35	1.58	0.32	0.32	0.00	0.32	0.00	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	59.34	1.10	0.00	0.55	1.65	0.00	0.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	90.76	0.94	1.18	0.47	0.24	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	62.67	0.97	0.65	0.48	0.32	0.32	0.16	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	75.82	0.54	0.54	0.00	0.72	0.54	0.18	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	64.90	0.84	0.42	0.42	0.00	0.63	0.63	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	65.06	0.39	0.59	0.20	0.00	0.39	0.20	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	67.32	0.63	0.63	0.00	0.63	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	106.72	1.15	0.99	0.82	0.66	0.82	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	74.80	0.93	0.56	0.19	0.75	0.56	0.37	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	79.52	1.34	0.00	0.19	0.38	0.77	0.19	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	84.82	1.64	1.02	0.00	0.41	0.41	0.41	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	77.37	1.21	0.40	0.20	0.81	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	91.29	1.08	0.54	0.81	0.54	0.27	0.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	87.14	1.68	0.96	0.24	0.24	0.96	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	93.40	1.18	0.71	0.71	0.94	0.71	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	111.99	1.90	0.73	0.44	0.44	1.17	0.44	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	76.55	0.21	0.42	1.05	0.42	0.42	0.42	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	81.29	1.40	1.22	0.17	0.52	0.87	0.35	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	88.14	1.20	1.41	1.20	0.80	0.60	0.20	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	79.10	1.40	0.93	0.00	0.47	0.70	0.23	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	71.97	0.96	1.20	1.20	0.24	0.48	0.00	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	79.28	0.30	0.89	1.49	0.00	0.30	0.00	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	77.80	0.96	1.91	0.72	0.00	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	78.05	1.21	1.01	1.21	0.61	0.81	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	68.45	1.64	0.41	0.61	0.61	0.41	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	83.84	0.67	1.33	0.67	1.33	0.44	0.67	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1161.35	27.98	0.00	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	68.49	1.06	1.06	0.71	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	67.93	1.66	1.99	0.66	0.33	0.33	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	484.07	3.36	5.87	2.52	1.68	0.84	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	157.52	0.92	2.30	0.46	0.92	0.46	0.46	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	75.52	0.65	1.30	0.97	0.32	0.97	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	61.02	0.96	0.64	0.32	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	152.76	1.26	1.57	0.63	1.26	0.94	0.31	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	81.79	0.71	1.41	1.41	1.41	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	94.77	1.12	2.24	0.56	1.12	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	433.10	5.57	4.78	0.00	2.39	1.59	1.59	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	165.13	1.70	1.70	0.34	0.68	0.34	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	98.13	0.00	1.95	0.65	1.30	0.00	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	94.42	1.06	0.71	0.71	0.71	1.06	2.13	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1390.10	32.33	16.16	0.00	0.00	16.16	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1784.83	15.79	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	137.97	0.00	1.95	0.49	1.95	1.46	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	129.42	1.49	0.99	0.50	0.00	1.98	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	136.04	1.88	1.41	0.00	0.94	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	134.79	0.00	1.32	0.66	0.33	0.33	0.00	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	87.54	1.86	0.00	1.55	0.31	0.62	0.62	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	105.48	0.61	1.83	0.61	0.31	0.61	0.61	0.61
Adipocyte - breast, donor1	11376-118A8	237.73	3.17	1.43	1.90	0.95	7.29	0.48	0.79
Adipocyte - breast, donor2	11327-117E4	162.03	2.73	2.09	1.12	1.28	2.41	0.16	0.32
Adipocyte - omental, donor1	11473-119C6	227.86	3.94	1.91	1.02	1.65	4.33	1.53	1.02
Adipocyte - omental, donor2	11474-119C7	174.17	3.74	1.49	0.00	2.24	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	112.87	2.34	1.67	0.67	1.34	3.35	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	135.89	0.64	1.28	0.00	3.19	3.83	1.28	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	75.87	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	166.20	1.81	0.90	1.81	2.26	0.90	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	56.65	0.87	1.04	0.35	0.17	0.17	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	156.46	2.93	1.56	0.98	0.20	1.17	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	84.16	0.77	1.03	1.03	0.77	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	121.27	1.67	1.67	1.39	2.51	1.39	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	78.77	0.00	0.00	0.59	0.59	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	117.59	2.17	1.29	0.88	0.32	0.88	0.40	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	92.31	1.29	0.97	0.65	0.00	0.97	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	75.18	1.60	0.00	0.53	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	61.76	0.56	0.56	1.11	1.11	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	74.44	0.83	0.00	0.00	0.42	0.00	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	92.68	2.51	1.00	0.00	0.25	0.75	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	79.85	2.62	2.29	0.33	0.33	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	60.89	1.22	0.00	0.30	0.30	0.30	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	215.25	2.65	2.21	2.21	3.98	1.33	0.88	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	34.78	0.00	0.36	0.00	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	0.00	3.59	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	138.53	1.44	0.90	0.54	0.54	1.08	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	43.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	118.95	2.67	1.44	1.44	1.85	0.21	0.41	0.41
Anulus Pulposus Cell, donor1	11248-116E6	156.42	3.09	1.60	0.34	0.80	0.23	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	93.06	0.98	0.98	0.00	0.24	0.24	0.24	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	182.86	3.59	1.80	1.80	1.35	2.25	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	205.78	4.34	2.17	0.00	3.04	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	149.82	2.14	2.14	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	203.86	2.39	2.09	1.79	1.79	2.69	1.49	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	236.49	3.79	2.53	0.00	1.26	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	132.67	1.32	1.98	0.66	1.32	0.66	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	170.89	2.60	2.27	1.30	1.95	4.22	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	200.49	1.46	2.91	2.91	1.94	2.91	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	122.34	1.78	1.78	2.38	2.97	0.59	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	203.76	4.52	3.01	1.13	1.88	1.51	2.26	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	206.09	4.35	4.35	1.45	0.73	1.45	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	126.63	1.25	0.00	0.00	2.51	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	244.63	4.61	2.31	1.65	1.81	3.13	0.99	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	200.63	2.73	4.09	0.00	2.73	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	166.02	2.87	1.21	1.66	0.90	2.11	0.75	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	192.35	3.75	3.75	0.54	2.68	5.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	192.34	3.02	2.27	1.70	2.08	1.89	0.38	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	156.10	3.47	2.94	1.87	0.27	2.14	0.80	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	183.38	2.93	2.93	0.00	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	207.16	4.31	2.16	0.66	2.32	1.49	0.83	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	115.27	3.60	1.20	2.40	2.40	2.40	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	198.25	0.00	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	194.69	5.49	2.06	1.72	1.20	2.06	1.72	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	88.09	0.00	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	195.14	6.80	2.91	0.00	0.49	1.46	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	237.92	3.79	2.66	1.52	3.79	3.04	1.52	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	138.10	2.42	1.21	1.21	0.00	1.21	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	224.59	7.98	3.42	1.71	3.99	1.14	2.28	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	178.50	3.21	1.71	1.50	0.43	1.07	0.21	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	130.59	1.81	0.52	0.77	0.52	0.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	171.26	3.28	2.35	0.47	1.41	2.35	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	189.71	2.25	2.89	1.93	1.61	1.93	1.29	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	125.57	2.85	2.14	1.43	1.43	3.57	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	184.26	1.75	2.34	4.09	1.17	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	179.14	3.91	2.11	1.81	2.41	2.71	1.20	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	130.68	3.56	1.19	0.00	1.19	0.00	0.00	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	231.90	3.56	2.03	0.51	2.03	3.56	2.54	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	203.75	3.82	2.29	1.78	2.55	1.78	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	112.46	3.18	0.00	0.00	1.91	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	198.07	3.02	1.29	1.29	3.02	1.73	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	199.83	4.23	1.91	1.06	2.33	1.69	1.48	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	122.08	0.58	0.87	1.45	0.87	2.61	1.16	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	213.51	2.83	1.89	2.83	1.89	0.94	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	185.29	1.86	2.20	1.36	1.02	2.20	0.51	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	155.20	2.32	0.00	2.32	0.00	6.95	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	259.85	6.34	4.23	0.00	2.11	2.11	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	187.61	2.14	1.50	1.07	1.29	1.72	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	120.93	3.61	1.80	3.61	0.60	1.80	2.41	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	183.70	3.64	2.19	0.73	5.10	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	222.07	3.22	3.45	1.61	1.61	2.30	1.15	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	130.07	0.00	0.00	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	179.49	2.29	1.78	0.76	1.27	1.27	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	200.04	2.27	2.48	2.27	1.86	1.65	1.45	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	146.88	1.84	3.06	1.84	0.92	1.53	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	222.75	4.30	1.43	1.91	1.43	2.39	0.96	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	181.61	3.10	2.88	0.89	1.77	2.22	1.11	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	123.59	0.00	0.00	0.00	4.58	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	159.52	3.32	2.22	2.77	2.77	2.22	1.11	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	189.33	2.12	0.53	1.32	0.79	0.00	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	130.84	3.27	1.09	2.91	1.09	2.18	0.73	1.09
Astrocyte - cerebellum, donor1	11500-119F6	108.57	2.21	0.98	0.12	0.98	0.61	0.49	0.25
Astrocyte - cerebellum, donor2	11580-120F5	54.60	1.54	1.03	0.68	0.17	0.34	0.51	0.00
Astrocyte - cerebellum, donor3	11661-122F5	30.62	1.05	0.84	0.84	0.63	0.42	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	210.89	5.23	1.39	1.74	0.70	0.70	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	180.54	1.46	2.10	1.13	1.13	0.16	0.32	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	209.27	3.13	2.68	0.75	1.34	0.45	0.00	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	171.45	1.49	1.38	0.69	0.23	0.69	1.72	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	169.88	2.13	0.75	0.13	0.50	1.38	2.00	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	174.22	1.02	1.14	0.68	1.14	0.68	2.39	0.23
Basophils, donor1	12241-129G9	265.98	3.40	6.80	4.97	4.71	0.52	4.18	0.00
Basophils, donor2	12242-129H1	204.93	3.61	4.69	5.77	4.69	1.44	5.05	0.00
Basophils, donor3	12243-129H2	215.79	4.12	7.20	7.64	5.88	0.88	1.32	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	60.37	1.51	0.22	0.22	0.22	0.00	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	21.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	137.46	3.14	0.00	0.63	0.63	0.00	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	133.50	3.33	1.87	0.21	1.04	1.04	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	97.41	0.92	0.92	1.15	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	89.61	0.90	0.90	0.36	0.72	0.18	0.36	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	107.28	0.31	0.21	0.41	0.21	0.00	1.85	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	124.37	0.23	0.47	0.00	0.70	0.00	0.47	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	106.80	2.56	1.92	3.52	1.28	0.32	2.24	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	10.34	0.00	20.68	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	136.94	0.56	7.89	6.20	9.58	0.56	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	111.17	1.67	5.57	7.05	5.01	0.37	1.30	0.19
CD14+ Monocytes, donor3	11381-118B4	104.72	1.54	2.85	3.73	2.85	0.44	2.20	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	383.24	7.36	5.94	6.51	7.08	5.66	0.28	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	357.09	3.03	3.79	4.17	4.17	4.17	1.90	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	402.05	5.92	7.23	5.92	8.88	6.57	0.99	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	237.06	4.77	4.19	5.20	5.49	1.45	1.59	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	165.36	2.11	3.02	3.62	2.41	2.11	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	223.63	6.16	4.26	4.97	5.92	2.37	3.08	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	168.40	4.35	3.01	5.86	5.86	1.67	1.34	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	142.42	3.04	3.59	3.59	3.86	1.38	1.93	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	194.87	4.21	4.46	6.20	6.20	1.74	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	170.54	3.72	6.66	7.64	5.29	1.96	0.98	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	153.48	2.67	4.27	3.38	4.99	1.25	0.71	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	242.44	2.83	5.88	6.75	5.44	1.74	1.74	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	131.35	3.28	3.28	5.85	4.92	1.40	0.94	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	144.15	1.58	3.17	5.81	5.81	1.06	1.58	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	133.12	1.11	5.55	5.55	6.66	4.44	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	183.26	4.46	4.46	5.80	4.61	1.34	0.74	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	170.01	1.80	2.79	4.19	5.39	1.60	2.59	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	273.57	4.37	2.08	7.29	6.04	1.67	0.83	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	219.86	4.58	5.26	5.95	5.26	1.60	1.14	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	199.96	2.26	5.20	7.92	4.30	2.94	1.13	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	157.13	2.62	4.80	4.36	5.67	0.00	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	154.94	3.23	3.50	6.46	5.92	1.08	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	152.48	3.66	3.66	5.23	4.36	0.35	0.17	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	159.07	3.37	3.37	4.21	4.63	2.95	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	205.21	3.31	4.96	9.00	8.82	1.29	0.92	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	189.17	3.87	4.23	7.75	9.51	1.41	1.41	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	201.37	2.19	7.02	9.65	4.83	2.19	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	148.74	3.31	4.18	5.41	5.58	1.74	0.70	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	147.93	4.09	2.23	4.09	4.83	0.00	1.12	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	226.11	3.88	4.10	6.68	5.17	2.16	2.59	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	142.09	4.50	6.14	8.19	7.78	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	170.60	4.40	3.94	5.79	5.33	1.16	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	195.80	3.48	3.48	8.35	5.57	1.39	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	431.13	6.76	4.80	8.06	9.59	5.01	1.09	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	446.51	6.24	4.85	5.77	7.62	4.85	1.85	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	401.82	5.20	6.28	5.85	5.85	3.90	1.73	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	412.20	9.65	9.19	16.04	10.28	1.25	0.47	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	353.13	6.81	7.34	12.23	8.38	0.87	1.05	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	437.91	6.47	8.92	18.73	10.70	1.11	0.89	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	406.75	6.38	3.32	6.38	6.89	6.89	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	506.98	5.05	5.93	5.05	6.59	8.34	1.10	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	507.84	8.21	6.11	8.21	6.95	6.95	1.47	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	191.04	0.00	2.03	0.00	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	238.65	2.03	0.68	0.00	2.71	0.00	4.07	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	182.27	0.00	1.04	1.04	1.04	0.00	4.14	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	249.99	1.07	1.07	2.13	0.53	0.00	3.73	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	281.44	2.68	0.00	0.00	0.54	0.00	3.22	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	217.60	1.40	2.11	1.40	0.70	0.70	4.91	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	213.34	1.57	0.78	1.57	1.57	2.35	3.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	210.93	0.00	1.32	0.00	1.32	0.00	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	66.57	0.00	0.82	1.64	0.00	0.00	5.75	0.00
CD19+ B Cells, donor2	11624-122B4	46.43	0.00	0.00	0.00	0.73	0.00	5.80	2.18
CD19+ B Cells, donor3	11705-123B4	54.52	0.50	0.50	0.00	0.00	0.00	2.52	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	81.62	2.02	1.62	2.42	0.40	0.00	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	69.11	1.60	0.80	2.00	0.40	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	48.19	0.00	1.00	1.00	1.00	1.00	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	68.54	2.81	1.69	1.12	1.12	0.00	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	146.17	3.01	1.50	0.75	1.88	0.38	1.88	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	155.81	3.61	3.61	3.16	1.58	0.90	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	117.11	0.00	0.00	0.71	0.00	0.71	3.21	0.00
CD4+ T Cells, donor2	11306-117C1	84.51	0.00	0.00	2.45	0.00	0.00	4.29	0.00
CD4+ T Cells, donor3	11382-118B5	110.41	0.61	0.61	0.91	0.00	0.91	4.27	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	326.96	0.51	0.77	0.77	0.77	1.79	4.85	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	258.96	0.67	0.00	0.22	0.45	1.80	7.19	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	265.33	0.57	0.00	0.00	0.00	0.00	5.75	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	147.44	0.95	0.00	0.95	0.00	0.47	2.37	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	165.75	0.00	0.70	0.00	0.70	0.00	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	112.07	0.00	0.00	0.00	0.00	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	318.51	0.87	1.01	1.73	1.59	2.02	5.35	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	175.56	0.68	0.68	0.68	1.53	2.03	4.74	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	171.52	0.32	0.97	0.48	0.48	1.13	4.84	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	238.94	0.90	0.90	0.90	0.45	1.34	4.48	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	244.57	0.70	1.05	0.35	1.05	1.40	6.29	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	270.15	0.44	0.88	2.20	0.44	2.20	7.92	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	340.69	1.26	0.84	1.26	0.42	1.69	6.75	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	186.16	0.42	0.83	0.62	0.62	1.87	4.57	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	166.40	1.00	0.67	0.33	0.67	2.67	6.35	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	181.65	0.54	0.27	0.82	0.82	0.54	5.17	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	194.55	0.54	0.54	1.07	1.07	1.07	9.11	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	177.53	1.79	0.00	0.00	5.38	0.00	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	423.33	2.04	1.48	1.30	1.67	2.97	8.72	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	293.08	0.65	1.30	1.08	1.08	1.73	9.96	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	350.74	0.63	0.84	1.05	0.42	3.78	18.28	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	192.64	0.00	1.01	0.51	0.51	0.51	3.54	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	214.89	0.43	1.73	0.87	0.00	0.87	8.23	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	267.59	2.18	0.00	0.00	0.44	1.74	9.15	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	324.14	0.99	2.47	2.97	1.98	2.47	4.45	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	285.26	0.92	1.85	0.92	0.00	0.92	5.54	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	274.98	1.40	1.40	1.40	0.00	2.79	5.58	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	354.47	2.49	1.11	1.66	2.49	0.28	3.88	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	424.77	1.72	2.45	0.98	0.74	0.00	4.17	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	269.50	0.00	0.00	6.16	4.62	3.08	10.78	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	353.82	2.15	3.94	4.66	2.15	2.15	10.39	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	358.71	1.38	1.38	1.38	4.15	0.00	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	131.94	0.33	1.64	0.98	0.33	0.33	5.89	0.33
CD8+ T Cells, donor2	11307-117C2	93.86	0.38	0.75	0.00	0.38	0.38	9.01	0.75
CD8+ T Cells, donor3	11383-118B6	94.68	0.25	0.50	0.76	1.26	0.50	6.56	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	103.00	0.69	1.38	0.46	0.46	3.90	0.00	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	83.87	0.96	0.24	0.48	0.72	4.31	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	97.95	0.27	0.27	0.27	0.27	1.64	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	163.92	1.50	0.90	0.60	0.30	6.00	0.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	84.23	0.72	0.24	0.00	0.48	2.40	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	104.82	0.68	0.45	0.23	0.45	4.09	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	102.56	0.87	0.22	0.00	0.00	2.39	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	83.17	0.53	0.26	0.53	0.00	2.11	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	89.82	0.23	0.23	0.00	0.00	2.81	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	78.19	0.00	0.30	0.00	0.00	2.72	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	70.30	0.87	1.45	0.29	0.29	1.74	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	74.87	0.27	0.00	0.00	0.53	2.13	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	61.29	0.88	0.00	0.00	0.88	2.19	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	60.57	0.00	0.00	0.91	0.91	2.28	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	55.94	0.00	0.75	0.00	0.00	2.24	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	115.61	1.08	0.72	0.00	1.08	5.76	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	99.26	0.86	0.29	0.00	0.00	4.60	0.86	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	97.58	1.89	0.71	0.00	0.71	7.07	0.71	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	120.42	1.90	0.95	0.63	0.32	4.12	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	94.11	1.23	0.92	0.00	0.00	5.23	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	97.46	0.64	0.32	0.64	0.64	1.60	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	69.99	0.38	0.00	0.38	0.38	1.15	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	61.09	0.39	0.39	0.00	0.00	1.18	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	50.68	0.00	0.00	0.00	0.00	2.27	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	36.94	0.80	0.00	0.80	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	40.57	0.00	0.00	0.00	0.70	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	62.11	0.00	1.00	0.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	69.45	0.00	1.83	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	114.63	0.99	0.49	0.99	0.49	0.99	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	253.29	3.68	2.53	1.68	2.10	0.84	1.37	0.21
Chondrocyte - de diff, donor1	11261-116G1	163.97	2.43	1.73	0.00	0.00	0.69	1.04	1.04
Chondrocyte - de diff, donor2	11338-117F6	125.80	2.84	0.71	1.07	0.36	0.71	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	103.20	1.71	1.37	0.46	0.46	0.91	0.23	0.57
Chondrocyte - re diff, donor2	11339-117F7	318.71	3.58	1.79	4.48	0.90	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	63.09	2.43	1.62	0.81	1.21	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	241.11	2.98	1.95	1.49	0.80	0.92	0.80	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	198.80	3.21	2.14	1.71	1.50	0.21	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	208.41	3.10	2.12	0.88	0.88	0.71	1.50	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	118.39	2.75	2.20	2.29	1.38	14.76	0.28	0.37
Corneal Epithelial Cells, donor1	11526-119I5	47.21	0.66	0.88	0.44	1.10	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	52.33	1.14	0.00	0.00	1.14	3.41	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	67.74	1.53	1.28	0.26	0.26	0.00	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	463.92	3.96	4.13	2.64	1.65	4.46	2.15	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	505.60	4.10	5.05	2.52	1.89	5.36	1.26	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	348.52	3.45	3.45	0.00	3.45	6.90	6.90	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	346.43	3.35	1.94	1.73	2.05	4.97	1.94	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	240.17	1.37	1.02	1.02	0.00	0.00	2.39	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	198.47	1.31	1.96	1.96	0.65	1.31	4.57	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	212.45	1.94	1.94	0.97	0.48	0.48	6.29	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	178.61	3.00	2.84	2.00	2.33	0.17	0.50	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	120.88	1.76	1.76	1.17	2.93	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	155.82	1.70	1.13	2.26	3.68	0.28	0.57	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	102.23	0.79	1.97	1.97	2.36	1.18	1.97	0.39
Endothelial Cells - Artery, donor1	11264-116G4	107.04	0.87	2.04	3.20	3.49	0.87	0.29	1.45
Endothelial Cells - Artery, donor2	11341-117F9	121.87	1.18	1.88	1.88	2.59	0.24	0.47	0.94
Endothelial Cells - Artery, donor3	11413-118E9	141.12	1.23	2.98	3.51	2.80	0.53	1.75	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	138.98	2.44	1.99	2.88	2.88	0.89	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	156.39	1.22	2.43	4.56	3.35	0.00	0.61	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	157.58	2.26	3.10	5.64	3.10	1.41	1.13	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	138.46	1.78	2.38	2.08	1.49	0.89	0.00	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	140.06	0.52	0.00	1.04	1.04	2.60	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	86.77	1.70	2.55	3.54	3.26	1.42	0.85	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	190.46	2.80	1.60	2.00	0.40	0.40	1.20	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	84.91	1.57	1.05	0.52	2.10	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	206.50	2.73	4.72	6.09	4.35	1.24	0.12	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	103.42	1.96	2.82	4.56	2.17	0.43	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	138.25	2.08	3.18	5.74	3.30	0.00	0.85	0.61
Endothelial Cells - Vein, donor1	11267-116G7	106.93	1.14	0.00	3.41	2.28	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	135.51	0.70	1.40	2.79	4.19	2.79	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	135.97	1.10	3.61	2.04	2.04	0.47	1.10	0.47
Eosinophils, donor1	12244-129H3	243.95	0.00	0.00	15.25	15.25	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	613.90	3.30	18.15	69.31	14.85	0.00	8.25	0.00
Eosinophils, donor3	12246-129H5	488.65	21.40	14.27	46.37	32.10	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	50.82	1.22	0.73	0.49	0.24	0.00	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	192.53	3.69	1.64	1.23	1.23	4.93	2.05	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	101.93	2.30	1.64	1.75	1.75	0.33	0.66	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	93.60	1.08	1.73	0.98	1.73	0.54	0.33	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	269.73	3.76	3.15	2.18	2.30	0.97	0.49	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	421.42	9.42	2.46	1.50	1.77	1.91	0.82	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	183.52	2.85	2.85	1.79	2.00	1.79	0.32	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	162.05	2.11	1.05	1.05	0.79	0.79	0.00	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	211.61	2.99	2.33	1.99	2.33	0.66	0.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	176.01	2.27	4.08	1.81	0.45	1.36	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	280.44	2.27	2.27	0.76	0.76	2.27	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	141.94	1.89	1.73	0.95	0.79	1.89	0.63	1.73
Fibroblast - Cardiac, donor4	11452-119A3	250.06	4.55	2.73	1.21	1.52	0.61	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	178.05	2.16	2.41	0.76	0.89	0.63	1.14	0.51
Fibroblast - Cardiac, donor6	11460-119B2	203.14	1.97	2.12	1.21	1.82	0.45	1.82	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	129.84	1.07	1.34	0.67	0.94	0.80	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	86.72	0.86	1.29	0.00	0.00	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	202.14	4.39	4.39	0.00	2.93	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	62.04	0.46	1.15	0.23	0.46	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	143.32	2.37	1.19	0.51	0.85	0.00	0.34	0.34
Fibroblast - Dermal, donor1	11269-116G9	173.74	2.11	2.35	1.41	2.11	1.41	0.70	1.64
Fibroblast - Dermal, donor2	11346-117G5	202.35	0.94	1.89	2.36	1.42	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	165.86	2.54	3.38	2.54	0.97	0.24	0.48	0.85
Fibroblast - Dermal, donor4	11450-119A1	155.32	2.83	2.15	1.02	1.58	0.00	0.11	0.34
Fibroblast - Dermal, donor5	11454-119A5	149.16	2.09	2.09	0.87	1.74	0.52	0.35	0.52
Fibroblast - Dermal, donor6	11458-119A9	183.05	3.41	3.09	1.30	1.46	0.32	0.81	0.49
Fibroblast - Gingival, donor1	11237-116D4	221.35	9.79	3.96	4.58	2.50	0.42	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	169.78	10.48	2.88	2.36	1.31	0.26	0.00	1.05
Fibroblast - Gingival, donor2	11318-117D4	193.33	2.90	2.11	1.05	1.98	0.66	0.40	0.66
Fibroblast - Gingival, donor3	11394-118C8	140.49	6.57	3.87	2.42	1.45	0.29	0.10	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	212.97	4.16	2.08	1.04	2.08	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	125.63	1.76	1.94	1.23	0.88	0.18	0.00	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	203.60	2.81	1.71	0.62	1.25	0.47	0.00	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	218.12	2.03	1.22	1.49	0.95	0.68	0.14	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	173.97	1.41	1.41	1.06	1.41	1.76	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	194.07	2.78	3.22	0.73	1.17	1.32	0.15	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	204.80	7.09	2.32	2.73	1.91	1.23	0.14	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	203.26	6.03	3.18	1.76	2.19	0.88	0.33	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	135.44	2.35	1.17	0.15	0.29	0.29	0.15	1.03
Fibroblast - Lung, donor1	11270-116H1	96.51	2.72	1.36	1.36	1.36	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	213.38	4.48	0.00	1.49	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	163.13	1.90	1.27	1.27	1.48	0.21	0.21	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	141.61	0.83	2.50	1.67	3.33	0.00	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	71.33	0.00	1.40	1.40	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	21.83	0.28	0.00	0.28	0.00	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	261.04	4.47	4.87	1.62	2.44	2.44	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	113.17	5.96	0.00	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	281.46	4.46	2.52	1.16	3.30	0.00	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	219.79	3.34	4.55	1.67	3.19	0.46	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	303.85	9.79	6.73	4.90	3.06	0.92	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	181.65	3.82	1.91	1.53	1.91	0.76	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	211.40	4.86	3.51	0.81	1.35	1.35	1.08	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	127.34	2.09	1.28	0.46	0.81	1.51	0.12	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	341.21	3.32	1.55	2.54	1.77	1.99	1.44	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	178.40	1.42	2.03	1.22	2.24	2.44	1.02	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	58.13	2.00	2.00	0.67	0.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	132.84	2.77	1.58	2.37	0.79	1.58	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	374.07	6.35	1.98	2.38	1.39	2.98	0.79	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	164.65	2.49	1.78	0.36	0.71	1.24	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	270.79	2.76	2.56	2.17	1.18	0.79	0.99	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	255.43	1.50	2.71	0.60	1.50	1.81	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	253.15	4.64	2.48	0.97	1.84	1.08	0.86	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	362.40	5.82	2.02	0.25	3.80	2.02	0.25	1.77
Fibroblast - skin normal, donor1	11553-120C5	246.12	3.77	1.80	0.98	1.15	1.80	0.66	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	377.55	5.21	2.21	1.80	1.40	1.40	0.40	0.40
Fibroblast - skin normal, donor2	11561-120D4	341.17	4.72	2.71	0.90	1.21	1.41	0.90	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	442.48	6.04	1.21	1.21	2.42	3.02	0.60	3.02
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	185.74	2.98	1.41	0.91	0.99	0.99	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	175.57	4.10	1.20	0.34	0.17	0.68	0.17	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	249.28	4.93	1.97	1.97	1.97	0.66	1.31	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	399.35	7.67	5.22	0.96	1.28	1.17	1.17	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	342.25	3.04	2.70	1.35	1.01	0.67	0.51	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	255.77	2.67	3.29	0.63	0.78	1.41	1.10	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	3944.44	0.00	0.00	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	102.84	0.00	0.00	0.00	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	496.15	6.41	5.03	3.81	6.41	6.93	3.12	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	528.29	12.49	9.89	6.25	4.94	5.73	2.86	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	430.03	5.11	8.69	6.64	5.11	4.85	3.07	2.04
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	65.84	0.77	0.00	1.53	0.00	0.00	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	87.42	0.64	0.64	0.00	2.55	0.00	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	132.08	1.43	0.57	1.14	0.57	0.29	0.57	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	94.58	1.38	1.10	0.28	0.28	0.28	0.55	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	110.05	2.28	0.23	0.23	0.23	0.23	0.68	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	106.00	1.98	1.19	0.00	0.20	0.00	0.59	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	87.76	0.79	0.53	0.26	0.00	0.00	0.53	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	71.75	0.33	0.33	0.65	0.00	0.00	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	113.21	1.77	0.44	0.44	1.77	0.00	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	98.78	1.41	0.99	0.28	0.57	0.57	0.28	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	107.01	1.85	0.49	0.37	0.86	0.25	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	87.03	2.42	0.81	0.27	0.27	0.27	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	180.88	1.86	1.24	0.99	0.50	0.25	0.37	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	184.11	2.21	2.49	0.97	0.55	0.42	0.28	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	131.13	1.42	0.81	0.61	0.61	0.00	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	120.02	1.83	0.91	0.46	0.46	0.68	0.23	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	176.88	2.49	1.37	1.12	1.62	0.37	0.12	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	142.29	2.40	1.31	0.87	0.22	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	106.08	0.30	1.48	0.89	0.30	0.30	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	137.50	1.91	1.11	0.48	0.79	0.16	0.48	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	116.18	1.56	0.89	0.89	0.45	0.22	0.45	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	118.36	1.41	0.81	0.40	0.40	0.00	0.60	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	161.50	1.87	1.87	0.68	1.36	0.17	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	192.33	2.22	1.33	1.06	0.80	0.62	1.06	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	168.47	1.35	1.04	0.52	0.73	0.00	0.10	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	164.63	1.71	0.85	0.51	0.68	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	141.53	1.99	1.33	0.66	1.00	0.00	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	171.63	2.75	1.25	0.58	0.50	0.50	0.83	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	166.00	1.02	1.43	1.02	1.23	0.41	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	116.15	1.44	1.44	0.00	1.44	0.21	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	134.43	1.84	1.73	0.92	0.46	0.00	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	130.74	2.17	0.50	0.33	0.83	0.17	0.33	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	105.37	0.88	1.10	0.44	0.44	0.00	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	142.18	2.21	1.48	0.12	0.61	0.25	0.12	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	112.33	1.62	1.13	0.49	0.16	0.32	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	91.08	0.96	0.64	0.00	0.32	0.32	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	149.81	1.80	1.71	0.95	0.76	0.47	0.19	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	119.11	1.11	0.79	0.63	1.11	0.16	0.47	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	132.28	2.74	0.61	0.61	0.91	0.00	1.22	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	155.13	2.20	1.46	0.63	0.63	0.31	0.42	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	106.05	0.88	0.88	0.66	0.22	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	116.15	1.68	0.56	0.84	0.84	0.56	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	175.08	2.31	1.39	1.02	1.11	0.56	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	140.65	1.60	2.14	0.53	0.00	0.53	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	168.46	1.22	1.22	0.92	0.77	0.15	0.92	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	193.14	2.59	2.33	1.42	1.04	0.39	0.13	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	152.34	1.36	1.08	0.81	0.54	0.54	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	148.03	0.55	0.92	0.92	0.92	0.55	0.37	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	138.61	1.75	1.97	1.32	0.44	0.44	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	150.75	1.98	1.98	0.00	2.98	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	153.15	3.30	2.24	0.79	0.79	1.06	0.40	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	136.19	1.01	2.02	1.21	1.82	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	276.02	5.08	2.03	1.02	1.27	1.27	1.27	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	141.13	2.19	1.59	0.20	1.00	0.00	1.19	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	100.61	1.69	0.92	0.31	0.46	0.00	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	122.34	1.84	1.43	0.00	0.20	0.20	0.20	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	80.74	0.31	0.00	0.00	0.94	0.00	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	77.99	0.85	0.28	0.00	0.28	0.57	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	69.64	0.46	0.00	0.00	0.46	0.00	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	86.62	0.00	0.00	0.00	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	93.61	0.39	0.00	0.77	0.39	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	54.55	1.60	0.00	1.60	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	83.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	67.05	0.33	0.33	0.00	0.33	0.00	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	76.18	0.41	1.24	0.00	0.00	0.00	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	79.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	74.95	1.12	0.56	0.00	0.00	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	77.46	0.98	0.33	0.00	1.31	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	72.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	80.79	0.32	0.64	0.00	0.00	0.00	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	72.69	1.70	0.00	0.00	0.00	0.00	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	68.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	70.44	1.15	0.00	0.00	0.00	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	63.04	0.59	0.30	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	74.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	82.01	0.83	0.41	0.00	0.83	0.00	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	73.41	0.92	0.46	0.00	0.46	0.00	0.69	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	53.05	0.38	0.77	0.38	0.38	0.38	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	63.56	0.98	0.33	0.00	0.00	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	53.51	0.67	0.00	0.67	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	72.43	1.54	0.77	0.00	0.00	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	87.30	1.71	1.37	0.34	1.03	2.40	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	57.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	49.54	0.94	0.94	0.00	0.00	0.00	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	63.37	0.60	0.60	0.00	0.60	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	61.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	55.84	0.80	0.00	0.00	0.40	0.00	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	61.18	0.99	0.49	0.49	0.00	0.00	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	56.66	2.36	1.18	0.00	0.00	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	54.84	0.58	1.17	0.00	0.58	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	62.76	1.32	1.32	0.44	0.00	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.99	0.85	0.00	0.00	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	55.51	0.00	1.79	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	43.67	1.94	0.00	0.00	0.00	0.00	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	174.62	2.28	2.28	1.14	1.14	5.71	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	158.84	1.25	2.49	0.42	0.83	0.42	0.83	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	192.28	2.25	2.25	1.12	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	118.94	0.63	1.90	1.59	1.90	0.32	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	98.59	1.67	1.67	2.51	0.42	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	100.03	1.28	1.28	0.23	0.81	1.39	0.46	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	97.90	1.01	1.86	0.17	0.51	0.84	0.34	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	86.91	1.14	0.46	0.23	0.46	0.91	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	91.27	1.09	0.77	0.55	0.22	1.42	0.44	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	96.50	2.15	1.07	0.86	0.86	1.29	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	76.21	2.15	0.43	0.65	0.65	0.43	0.43	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	98.51	1.49	0.37	0.50	1.00	0.50	0.25	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	93.84	1.54	0.86	0.00	1.72	0.51	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	87.46	0.00	1.92	0.00	0.32	0.32	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	69.95	1.12	1.12	2.24	1.68	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	41.12	0.00	0.43	1.73	2.16	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	79.31	5.29	2.64	0.00	7.93	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	104.41	2.82	0.35	1.06	0.35	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	52.31	1.45	0.00	0.00	1.45	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	165.92	2.10	1.75	0.87	1.40	1.05	0.87	0.35
Hepatocyte, donor1	11523-119I2	69.00	0.00	0.00	0.00	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	80.80	0.00	0.00	1.08	2.15	1.08	1.08	1.08
Hepatocyte, donor3	11684-122I1	68.72	2.45	0.00	1.23	0.61	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	52.87	0.65	0.00	0.00	0.65	0.00	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	80.40	1.57	0.17	0.52	0.00	0.00	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	227.49	2.61	1.92	1.51	1.23	0.69	1.10	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	0.00	0.00	0.00	3.18	0.00	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	62.30	0.00	0.00	0.00	1.38	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	65.07	5.01	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	51.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	86.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	71.47	1.62	0.00	0.00	0.00	0.00	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	58.36	0.00	0.00	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	0.00	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	54.26	1.32	0.00	0.00	0.00	1.32	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	53.21	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	0.00	10.48	0.00	0.00	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	62.99	1.26	0.63	0.00	1.26	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	52.59	0.00	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	57.50	1.29	0.65	0.00	0.00	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	57.96	1.61	0.00	0.00	0.00	0.00	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	72.52	0.00	0.81	0.81	0.00	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	59.19	1.26	0.42	0.84	1.26	0.00	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	91.62	1.61	0.00	0.00	1.61	0.00	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	67.40	0.00	0.92	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	72.69	0.00	0.47	0.00	1.42	0.47	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	51.70	0.00	0.00	0.00	0.00	0.91	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	65.64	0.00	0.00	1.08	0.00	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	47.01	1.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	56.75	0.64	0.00	0.00	0.64	0.00	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	52.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	62.84	0.00	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	69.76	0.31	0.31	0.62	0.00	0.62	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	54.44	0.00	0.00	1.76	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	56.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	70.23	0.00	0.00	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	0.00	4.43	0.00	0.00	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	71.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	57.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	55.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	40.54	0.00	0.00	0.00	1.07	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	1.39	0.00	0.00	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	38.66	0.00	0.00	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	40.18	0.00	0.00	1.06	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	301.35	4.57	3.10	3.35	2.94	2.77	2.45	1.22
Keratinocyte - epidermal, donor2	11349-117G8	100.73	1.17	1.17	0.59	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	306.97	3.22	3.69	1.51	2.27	1.80	1.42	2.27
Keratinocyte - oral, donor1	11251-116E9	286.29	3.41	1.36	2.04	0.79	0.23	0.45	0.79
Keratocytes, donor1	11527-119I6	63.26	0.34	1.03	0.34	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	52.73	1.17	0.00	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	91.09	1.38	1.78	1.19	0.79	0.20	0.00	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	50.55	0.00	2.20	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	163.97	1.08	2.16	1.08	1.08	1.08	1.08	3.24
Lens Epithelial Cells, donor2	11609-120I7	172.42	3.34	2.42	1.15	1.04	0.00	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	288.20	5.55	3.13	2.12	1.21	1.82	1.31	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	176.80	2.49	2.25	2.13	2.13	1.54	1.42	1.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	104.65	1.12	1.67	2.23	1.40	0.56	0.84	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	138.84	1.26	2.36	2.99	2.99	0.00	1.26	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	115.07	2.15	0.00	2.69	1.08	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	89.19	0.95	1.58	1.26	2.52	0.95	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	113.31	1.40	1.83	2.16	1.83	0.86	0.75	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	124.76	2.05	0.41	2.46	2.46	1.23	1.64	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	81.66	1.01	1.01	2.53	1.01	0.00	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	98.24	1.13	1.83	2.53	1.41	0.70	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	111.94	1.19	0.79	1.19	1.58	1.19	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	111.68	0.58	1.94	1.94	1.16	1.16	0.78	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	80.72	1.11	0.74	0.93	1.11	0.37	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	112.89	3.48	1.39	2.09	1.74	1.05	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	110.91	0.95	0.48	0.72	0.95	0.72	0.95	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	100.26	1.51	1.51	1.65	1.65	0.69	0.82	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	135.19	1.85	0.31	3.70	3.08	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	86.35	1.56	1.25	3.12	1.87	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	108.15	1.65	0.91	1.83	1.28	0.55	1.28	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	112.23	1.65	1.97	1.32	1.97	0.99	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	79.37	1.17	0.88	0.59	0.59	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	90.11	0.25	0.50	1.74	1.49	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	121.24	0.48	1.45	2.91	1.94	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	99.64	0.81	2.69	1.89	1.89	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	115.50	0.91	1.67	1.67	1.36	0.91	1.36	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	122.35	0.52	0.52	1.56	2.07	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	110.98	0.63	2.09	2.30	2.72	0.63	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	113.83	2.11	1.95	2.26	2.26	0.30	0.75	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	125.19	0.69	0.69	1.38	2.75	0.69	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	111.76	1.69	0.94	0.94	0.56	0.00	0.94	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	107.83	1.59	1.06	1.70	1.70	0.95	0.74	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	117.27	0.48	0.97	2.42	3.88	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	91.30	0.66	1.65	2.32	0.33	0.33	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	98.49	1.12	1.86	0.99	1.61	0.87	0.99	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	139.20	1.85	2.59	1.85	1.85	0.74	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	94.63	0.74	0.74	2.96	1.24	0.25	0.99	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	100.92	0.96	1.24	1.92	0.82	0.69	1.24	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	156.96	0.96	2.25	2.25	1.93	0.64	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	116.56	1.22	0.61	1.22	0.91	0.30	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	122.47	1.54	1.26	2.10	1.26	0.84	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	116.98	0.36	2.49	2.49	0.00	1.42	1.42	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	78.05	0.48	0.97	1.45	1.94	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	82.32	0.62	0.78	1.71	1.40	0.78	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	122.11	2.15	1.07	3.58	1.79	0.72	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	107.48	0.98	1.96	1.96	0.65	0.33	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	75.34	0.47	1.18	1.65	2.59	0.71	1.18	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	188.35	1.36	1.73	2.23	1.73	0.99	0.99	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	85.03	1.79	0.77	1.54	1.02	0.51	1.02	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	115.46	0.60	1.49	1.49	1.49	0.60	1.79	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	52.12	0.00	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	55.23	2.30	0.77	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	45.28	2.23	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	38.08	0.42	0.00	0.00	0.00	0.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	33.06	0.70	0.70	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	40.16	0.00	0.00	0.00	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	45.34	0.00	0.00	0.00	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	35.68	0.00	2.38	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	53.61	0.23	0.23	0.23	0.00	0.23	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	42.17	1.16	1.16	0.29	0.29	0.58	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	46.37	0.90	0.45	0.45	0.00	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	61.92	1.08	0.68	0.27	0.14	0.27	0.81	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	38.00	0.00	0.00	0.00	0.51	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	51.87	2.12	0.71	0.35	0.35	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	38.65	2.00	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	32.09	1.53	0.00	0.00	1.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	49.09	1.33	0.80	0.27	0.53	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	64.24	1.51	1.51	0.76	0.76	0.57	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	43.56	2.45	0.00	0.00	0.00	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	49.74	0.00	0.00	0.00	0.00	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	57.68	1.25	0.62	0.21	0.21	0.21	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	61.38	0.56	0.28	0.28	0.56	0.00	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	45.33	1.03	0.00	1.03	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	61.25	1.45	1.74	0.29	0.58	0.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	46.93	1.49	0.30	0.00	0.00	0.90	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	61.41	0.55	1.66	0.55	0.55	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	43.83	1.41	0.00	0.35	0.71	0.35	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	46.84	0.74	0.37	0.00	0.37	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	44.90	0.00	0.00	0.00	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	41.83	0.38	0.38	0.38	0.00	0.00	1.15	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	41.89	0.00	1.13	0.57	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	47.59	0.82	0.00	0.00	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	43.83	0.90	0.45	0.45	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	45.96	3.59	0.72	0.00	1.44	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	53.78	2.24	1.49	0.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	40.88	1.49	0.74	0.00	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	52.55	0.43	0.00	0.00	0.86	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	47.10	0.00	0.00	0.86	0.86	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	54.97	1.00	1.33	0.00	0.67	0.67	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	44.04	0.60	0.00	0.00	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	42.66	0.00	0.71	0.00	0.71	0.00	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	54.65	0.69	0.69	0.69	0.00	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	38.65	0.00	0.00	0.54	0.54	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	57.24	0.00	1.35	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	44.82	1.11	0.00	0.74	1.11	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	59.31	1.16	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	52.89	0.00	1.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	54.42	0.80	0.40	0.00	0.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	39.25	0.00	0.00	0.00	0.00	0.73	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.22	0.77	0.00	0.00	0.77	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	40.45	0.99	0.99	0.00	0.49	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	33.87	0.94	0.94	0.00	0.00	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	51.29	1.01	1.51	0.00	1.01	0.50	1.51	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	52.27	1.35	0.90	0.45	0.45	0.45	0.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	37.86	0.00	0.00	0.00	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	52.11	0.45	0.45	0.00	0.45	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	50.83	0.00	0.78	0.00	1.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.31	0.00	1.32	0.00	0.00	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	47.74	0.00	1.04	0.00	0.52	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	57.32	1.31	0.44	0.44	0.00	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	48.64	0.56	0.56	0.00	0.00	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	52.56	0.88	2.21	0.00	0.88	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	57.86	0.00	1.93	0.00	0.77	0.00	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.01	1.52	1.01	0.51	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	54.79	0.96	0.48	0.00	0.00	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	55.66	0.40	0.40	0.00	1.19	0.40	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	37.06	0.61	0.00	0.00	0.00	0.61	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	42.19	0.69	0.00	0.00	0.69	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	58.14	1.14	0.76	0.00	0.38	1.14	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	42.86	2.07	0.00	0.00	1.03	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	36.88	1.21	1.21	0.00	0.00	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	60.84	0.95	1.27	0.00	0.63	0.63	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	37.32	0.00	0.00	0.00	0.53	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	36.78	0.57	0.00	0.57	0.57	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	49.37	2.06	0.51	0.00	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	48.81	0.71	0.00	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	46.53	0.57	0.57	0.00	0.57	0.57	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	54.08	1.66	0.83	0.42	0.83	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	53.25	0.78	0.00	0.00	0.00	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	45.10	0.00	0.84	0.00	0.84	0.84	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	40.42	0.46	0.00	0.00	0.46	0.00	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	35.46	0.67	0.00	0.00	0.00	0.00	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	50.79	1.60	1.60	0.00	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	52.13	0.81	0.81	0.81	2.02	0.81	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	38.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	56.90	0.89	0.00	0.00	2.67	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	42.17	1.14	0.57	0.00	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	36.04	0.00	0.00	0.00	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	52.53	2.74	1.64	0.00	1.64	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	60.58	0.00	0.89	0.00	0.89	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	82.15	1.30	1.56	0.52	0.00	1.30	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	45.75	0.66	0.00	0.66	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	49.89	2.08	0.00	0.00	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	373.10	5.70	4.56	5.70	4.10	6.84	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	409.22	6.24	2.57	3.85	2.20	5.51	1.84	0.18
Macrophage - monocyte derived, donor3	11389-118C3	325.34	3.67	4.85	3.54	2.88	3.93	0.39	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	446.59	10.62	4.25	4.78	11.68	5.31	10.62	0.00
Mallassez-derived cells, donor2	11929-125I3	785.61	8.71	7.13	4.75	8.08	8.56	5.23	1.58
Mallassez-derived cells, donor3	11930-125I4	819.19	20.57	14.32	13.62	18.62	9.17	9.87	1.95
Mammary Epithelial Cell, donor1	11273-116H4	289.66	4.78	2.29	1.59	1.40	2.29	1.69	0.50
Mammary Epithelial Cell, donor2	11350-117G9	285.21	3.47	1.74	1.74	2.90	1.16	1.45	1.45
Mammary Epithelial Cell, donor3	11422-118F9	174.10	2.74	1.25	1.00	0.75	1.00	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	588.45	8.14	6.10	2.03	1.36	7.46	2.71	0.68
Mast cell, donor1	11563-120D6	373.19	2.70	2.60	1.73	1.51	4.65	3.46	1.08
Mast cell, donor2	11565-120D8	327.78	3.57	2.08	2.08	1.78	1.49	1.78	0.59
Mast cell, donor3	11566-120D9	304.37	3.60	2.03	1.58	1.35	1.58	1.35	0.90
Mast cell, donor4	11567-120E1	358.48	2.66	1.95	1.60	0.89	1.24	1.24	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	304.07	2.55	0.78	1.55	2.00	3.11	0.89	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	139.50	1.75	1.75	2.33	1.17	3.50	1.17	1.17
Mast cell, expanded, donor5	11939-126A4	367.45	3.33	2.18	1.95	2.87	5.62	1.84	2.06
Mast cell, expanded, donor8	11941-126A6	260.09	2.85	1.17	0.84	0.84	6.86	3.68	1.51
Melanocyte - dark, donor1	11502-119F8	211.04	2.39	2.89	3.18	2.79	1.49	2.09	0.20
Melanocyte - dark, donor2	11582-120F7	132.55	1.73	1.04	2.08	1.04	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	322.22	3.19	1.67	0.94	1.09	1.45	1.09	0.51
Melanocyte - light, donor1	11274-116H5	157.03	1.65	1.18	0.47	0.47	0.00	0.47	0.24
Melanocyte - light, donor2	11351-117H1	128.30	1.36	0.00	0.00	0.68	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	84.99	1.73	0.87	1.73	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	224.49	2.39	2.50	0.83	1.35	0.62	0.73	1.87
Melanocyte, donor2 (MC+2)	12739-135I3	181.80	1.08	2.15	0.54	1.34	0.00	1.08	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	144.64	1.34	1.07	0.54	0.27	1.07	0.54	0.54
Meningeal Cells, donor1	11493-119E8	252.96	5.21	2.23	2.36	2.48	0.87	0.12	0.50
Meningeal Cells, donor2	11573-120E7	190.14	1.76	1.76	1.32	1.32	0.44	0.88	0.00
Meningeal Cells, donor3	11654-122E7	305.88	5.62	2.85	3.10	1.87	1.39	0.33	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	207.31	3.14	2.57	1.14	0.29	0.00	0.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	192.71	3.32	2.21	1.41	1.41	1.21	0.50	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	30.23	0.00	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	40.55	1.31	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	168.64	2.87	2.15	5.02	0.72	0.72	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	250.95	3.39	1.91	0.21	1.06	0.85	0.85	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	194.52	2.51	1.01	1.01	2.01	0.50	3.02	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	109.44	1.32	1.10	0.44	0.88	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	71.60	0.73	0.00	2.19	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	69.36	1.64	1.84	0.82	1.23	0.41	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	170.50	2.35	1.66	0.69	1.94	0.42	0.42	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	43.12	0.37	0.37	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	154.86	1.18	1.05	0.92	1.18	0.66	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.72	0.30	0.00	0.00	0.00	0.30	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	0.00	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	97.98	1.28	0.64	0.00	0.64	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	309.08	7.44	4.25	0.71	1.77	1.06	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	166.99	1.56	0.63	0.94	0.00	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	148.77	2.18	0.73	1.45	1.45	0.73	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	424.55	5.30	4.24	2.39	5.83	7.42	3.71	1.06
Mesothelial Cells, donor2	12156-128G5	341.82	5.00	7.51	1.50	3.50	7.51	2.00	0.50
Mesothelial Cells, donor3	11402-118D7	301.49	4.12	4.05	2.96	3.18	5.42	3.25	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	220.10	6.75	1.35	0.00	1.35	4.05	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	304.89	4.68	5.91	2.46	2.71	3.94	1.72	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	291.51	6.18	2.94	2.06	2.36	9.13	2.36	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	82.97	3.46	6.91	6.91	3.46	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	254.78	5.89	2.79	2.79	2.79	6.51	1.86	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	213.45	2.70	2.07	2.07	2.70	4.98	2.07	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	39.37	0.00	0.00	0.00	2.32	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	235.00	1.75	4.50	1.50	2.75	5.01	1.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	257.41	3.26	1.86	1.86	1.40	4.65	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	227.19	5.28	2.24	1.63	2.64	4.47	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	235.20	3.96	3.17	0.79	1.19	6.34	1.58	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	186.72	2.65	3.54	1.77	1.77	7.08	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	244.68	4.18	2.28	3.04	1.52	5.32	1.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	86.85	1.32	0.00	2.63	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	175.51	3.18	2.76	2.33	1.70	4.24	1.27	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	116.94	0.92	0.00	2.76	0.92	3.68	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	164.82	3.58	2.09	2.68	1.79	3.58	1.49	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	100.60	3.35	0.00	0.00	1.68	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	177.89	2.76	3.01	2.51	1.76	4.52	0.75	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	197.98	4.28	2.61	0.71	1.90	5.47	0.95	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	102.28	2.76	1.66	2.76	4.98	2.76	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	203.54	3.68	2.99	1.61	1.84	3.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	231.58	4.00	2.52	0.21	0.84	4.21	1.05	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	206.27	2.24	2.65	2.24	1.83	3.87	1.22	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	207.03	2.15	2.15	1.29	2.79	5.15	1.07	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	191.84	2.22	1.78	1.11	0.89	6.45	0.44	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	160.32	3.94	2.85	1.53	2.63	3.29	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	170.84	4.06	2.03	2.03	1.01	4.56	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	66.28	0.00	3.31	1.66	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	184.00	5.44	1.63	3.53	0.82	3.26	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	213.50	2.35	2.65	1.18	2.94	4.41	1.76	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	74.14	2.18	2.18	2.18	3.27	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	158.10	3.36	1.44	0.96	1.92	3.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	202.52	2.40	1.60	0.80	2.40	4.00	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	117.92	1.37	1.37	0.00	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	218.25	1.50	0.50	4.00	6.51	5.01	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	188.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	93.77	0.00	4.08	4.08	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	165.53	3.50	1.75	3.50	3.07	3.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	116.99	1.10	3.31	2.21	3.31	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	135.76	2.56	1.92	1.92	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	223.37	2.48	2.98	4.71	2.23	4.96	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	140.57	3.48	2.78	1.39	2.78	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	145.85	2.21	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	221.88	2.74	1.37	1.71	1.37	4.44	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	172.42	4.81	3.06	0.44	0.88	2.63	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	138.49	1.78	2.49	1.78	0.36	1.07	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	212.66	2.24	1.40	0.84	1.68	3.93	1.96	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	220.70	4.16	3.33	1.25	2.08	8.73	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	127.62	1.75	0.58	1.75	0.00	0.58	0.58	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	196.69	1.51	1.51	1.21	2.41	4.22	1.21	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	235.83	3.34	2.09	0.83	1.67	7.51	2.09	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	158.81	0.00	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	172.70	0.00	0.00	0.92	0.92	2.77	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	228.79	1.14	2.28	1.71	2.85	2.85	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	190.97	1.11	2.07	0.69	0.69	2.21	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	198.25	2.07	1.55	1.04	1.55	3.11	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	199.47	1.72	2.14	0.43	0.00	3.86	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	132.12	1.91	0.64	0.00	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	159.33	1.33	1.33	1.07	1.60	3.47	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	238.27	2.39	4.19	2.10	2.39	5.09	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	151.85	1.41	1.13	0.71	0.28	1.70	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	172.00	1.91	0.64	0.64	1.27	2.23	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	260.49	3.54	2.43	0.66	1.11	6.19	1.55	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	169.88	1.14	1.14	1.14	0.38	3.03	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	217.06	0.57	0.85	0.85	0.85	3.13	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	244.57	0.74	0.98	0.98	1.72	5.65	0.98	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	119.91	0.00	3.91	1.30	1.30	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	184.06	0.88	0.88	1.47	1.18	2.94	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	220.28	2.88	0.00	0.58	1.44	6.92	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	223.38	3.30	0.41	0.82	1.65	1.65	2.06	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	176.59	2.38	1.79	0.60	0.30	2.98	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	154.44	0.00	0.00	0.00	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	160.40	1.78	1.78	0.00	3.56	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	226.39	2.63	2.96	1.31	1.64	3.29	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	198.82	0.00	1.05	3.16	1.05	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	187.80	2.77	2.37	1.98	2.17	2.57	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	184.40	1.86	2.79	0.00	3.73	4.66	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	235.83	3.76	2.25	4.13	2.25	4.13	0.75	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	206.68	2.93	1.86	1.07	2.93	3.20	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	263.41	3.73	1.81	3.51	2.26	3.17	0.45	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	174.60	3.68	3.68	3.68	0.74	1.47	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	185.41	1.47	1.10	2.20	4.03	5.50	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	222.45	0.00	0.00	4.67	1.56	4.67	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	177.43	3.21	2.67	2.67	1.60	3.21	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	170.01	3.86	0.00	0.00	0.00	7.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	190.88	2.02	2.02	1.01	3.03	3.03	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	141.67	2.11	2.11	1.26	0.84	2.95	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	47.67	1.36	0.00	1.36	1.36	1.36	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	88.38	0.64	0.64	0.64	0.64	0.64	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	117.43	2.43	0.00	1.62	0.81	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	48.33	1.51	3.02	1.51	3.02	1.51	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	0.00	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	58.72	0.00	0.00	0.00	9.79	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	109.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	298.16	3.66	3.88	3.02	1.72	1.94	0.86	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	140.58	2.61	2.09	1.57	1.57	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	80.77	1.33	2.67	2.67	0.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	58.01	1.25	1.25	2.09	2.09	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	238.63	4.75	3.42	1.52	1.14	0.38	0.76	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	108.52	1.60	0.00	4.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	27.20	0.68	0.68	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	621.12	7.35	14.70	3.68	1.84	0.00	3.68	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	41.02	0.00	0.84	1.26	0.42	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	83.45	1.86	1.16	1.86	1.63	0.46	0.23	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	55.67	0.81	0.27	0.81	0.54	0.00	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	72.95	1.05	1.05	0.42	0.42	0.21	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	957.59	33.40	11.13	0.00	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	68.00	0.99	0.99	0.99	0.50	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	75.52	0.00	0.27	0.54	0.81	0.27	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	48.06	0.45	0.23	0.68	0.68	0.00	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	43.76	0.98	0.33	0.65	0.49	0.49	0.33	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	82.38	1.09	0.73	0.73	0.55	0.55	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	38.19	0.00	1.59	1.06	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	49.83	0.60	0.60	1.80	1.20	0.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	139.48	3.28	0.98	0.98	0.98	0.33	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	39.35	0.98	0.65	0.81	0.49	0.49	0.49	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	76.73	0.88	0.71	0.53	1.06	0.18	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	38.68	0.70	1.41	2.11	0.70	0.00	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	56.08	0.46	0.00	2.30	1.38	0.00	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	42.74	0.64	0.00	1.29	0.96	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	224.87	4.48	2.76	1.38	1.03	0.69	0.69	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	793.93	15.17	17.70	2.53	5.06	10.11	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	53.91	1.34	1.11	0.67	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	27.52	0.42	0.42	0.42	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	55.30	1.90	0.47	0.71	0.47	0.71	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	54.94	1.29	0.43	0.86	0.43	0.00	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1796.52	54.17	0.00	9.03	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	42.99	0.33	0.33	1.67	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	32.46	0.00	0.45	0.45	1.35	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	31.35	0.00	0.40	0.79	0.40	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	32.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	79.46	1.14	0.76	0.38	0.38	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	41.39	0.33	0.65	0.98	0.98	0.65	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	27.02	0.44	0.87	0.44	0.00	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	64.22	1.36	0.90	1.36	1.36	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	37.92	0.88	0.00	0.00	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	39.89	0.00	0.66	0.00	0.00	0.00	0.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	43.16	1.49	0.50	0.00	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	39.43	0.00	0.00	0.38	0.38	0.38	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	94.67	2.72	0.00	0.91	1.51	0.00	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	88.63	1.33	0.88	1.11	1.77	0.66	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	27.78	0.68	0.00	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	301.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	47.56	1.22	0.61	1.83	1.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	34.62	1.57	1.26	0.31	0.63	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	27.84	0.61	0.61	0.00	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	55.38	0.79	0.79	0.00	0.79	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	175.71	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	404.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	268.21	4.72	3.11	2.86	2.11	1.24	0.50	0.50
Myoblast, donor2	11322-117D8	146.14	3.07	3.26	2.11	1.34	0.38	0.19	0.38
Myoblast, donor3	11398-118D3	283.69	5.04	2.86	2.02	2.02	1.85	1.35	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	148.85	0.73	0.73	0.44	0.44	0.29	2.19	1.02
Natural Killer Cells, donor1	11230-116C6	184.20	0.92	0.62	0.92	0.62	1.23	5.84	0.62
Natural Killer Cells, donor2	11311-117C6	103.43	0.00	0.60	0.30	0.00	0.30	7.24	0.90
Natural Killer Cells, donor3	11387-118C1	120.19	0.18	0.18	1.29	0.00	0.37	7.73	0.92
Neural stem cells, donor1	11275-116H6	167.68	4.72	2.18	0.36	0.36	0.36	1.09	0.00
Neural stem cells, donor2	11352-117H2	188.71	7.70	0.00	1.93	5.78	1.93	1.93	0.00
Neurons, donor1	11494-119E9	118.34	1.14	1.14	0.00	0.00	0.00	2.28	0.00
Neurons, donor2	11574-120E8	168.65	3.30	1.10	1.10	1.54	0.00	0.66	0.22
Neurons, donor3	11655-122E8	90.44	2.47	3.29	0.00	0.00	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	827.78	10.21	16.70	60.32	36.19	0.00	6.50	10.21
Neutrophils, donor2	11314-117C9	687.03	5.80	11.60	34.79	26.09	0.00	2.90	14.49
Neutrophils, donor3	11390-118C4	1530.16	18.33	30.54	107.51	68.41	0.61	7.94	9.77
Nucleus Pulposus Cell, donor1	11252-116F1	141.65	2.61	1.19	0.83	0.95	0.12	0.12	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	70.00	0.33	0.33	0.65	0.65	0.00	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	98.27	1.00	2.61	0.20	0.00	0.00	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	111.36	1.38	1.24	0.83	0.69	0.96	0.55	0.41
Olfactory epithelial cells, donor2	11934-125I8	140.40	1.45	0.72	0.87	1.01	0.58	0.58	1.59
Olfactory epithelial cells, donor3	11935-125I9	107.72	1.25	1.14	0.68	0.91	0.34	0.34	0.45
Olfactory epithelial cells, donor4	11936-126A1	130.32	2.63	2.43	0.78	0.97	1.07	0.58	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	346.05	3.61	3.61	1.20	1.81	0.60	1.81	0.00
Osteoblast - differentiated, donor1	11276-116H7	131.45	3.40	1.06	0.85	1.28	1.06	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	75.45	1.14	4.57	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	65.17	0.62	1.86	0.62	1.24	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	196.41	2.54	1.56	1.17	0.98	1.37	1.17	0.59
Osteoblast, donor2	11354-117H4	346.94	4.92	2.81	1.40	1.40	2.11	0.70	0.00
Osteoblast, donor3	11426-118G4	247.40	4.80	4.27	1.60	1.78	1.24	0.71	0.53
Pancreatic stromal cells, donor1	11249-116E7	232.49	3.12	1.94	1.10	1.35	0.59	0.51	1.10
Pericytes, donor1	11491-119E6	29.26	0.78	0.33	0.00	0.11	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	22.18	0.68	0.00	0.00	0.23	0.00	0.23	0.45
Pericytes, donor3	11652-122E5	90.74	2.64	1.22	0.41	1.02	0.41	0.00	0.81
Perineurial Cells, donor1	11499-119F5	201.18	3.39	2.15	0.68	1.02	0.34	0.34	0.34
Perineurial Cells, donor2	11579-120F4	223.40	3.04	1.47	2.21	1.10	0.55	1.20	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	299.30	3.19	2.55	6.37	4.14	0.64	4.46	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	142.02	2.20	4.65	2.69	2.69	0.98	1.22	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	165.26	2.07	2.72	2.98	3.24	0.65	4.27	0.52
Placental Epithelial Cells, donor1	11278-116H9	86.82	1.67	0.24	0.24	0.72	0.96	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	84.28	2.22	1.11	0.00	0.00	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	60.86	1.57	0.59	0.00	0.59	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	139.24	0.95	3.16	1.27	1.90	5.70	0.63	1.58
Preadipocyte - breast, donor1	11467-119B9	162.83	3.38	1.50	1.50	0.94	3.00	0.38	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	519.37	6.79	2.22	1.57	1.83	6.27	0.78	0.65
Preadipocyte - breast, donor2	11328-117E5	185.07	2.25	2.03	1.13	1.13	1.13	0.90	0.00
Preadipocyte - omental, donor1	11468-119C1	161.44	2.66	1.60	1.07	0.75	2.77	0.64	0.75
Preadipocyte - omental, donor2	11329-117E6	239.19	3.06	0.87	0.44	1.31	3.06	0.44	1.75
Preadipocyte - omental, donor3	11403-118D8	264.87	4.58	2.86	2.58	3.15	3.58	2.15	1.00
Preadipocyte - perirenal, donor1	11469-119C2	151.58	5.91	0.00	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	190.11	3.07	2.76	1.54	1.23	1.54	2.15	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	277.83	3.54	3.01	1.42	1.59	2.12	1.95	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	220.01	3.24	3.24	2.72	1.70	1.70	0.68	1.70
Preadipocyte - visceral, donor1	11280-116I2	325.46	3.35	1.86	1.30	1.30	0.84	0.37	0.84
Preadipocyte - visceral, donor2	11357-117H7	183.61	1.84	2.76	0.92	1.38	0.92	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	199.16	2.19	2.19	1.15	0.73	0.73	0.73	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	90.36	0.75	1.21	0.60	0.30	0.15	0.30	0.60
Prostate Epithelial Cells, donor2	11331-117E8	228.85	4.06	3.39	3.39	3.93	2.30	2.44	1.49
Prostate Epithelial Cells, donor3	11404-118D9	102.27	1.78	1.71	1.29	1.78	0.61	0.37	0.73
Prostate Stromal Cells, donor1	11254-116F3	256.85	3.87	3.64	1.59	1.71	0.80	0.80	0.57
Prostate Stromal Cells, donor2	11332-117E9	198.84	2.51	2.51	1.43	2.15	1.26	0.36	0.36
Prostate Stromal Cells, donor3	11405-118E1	128.88	2.40	1.46	0.52	0.52	0.31	0.31	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	76.28	1.82	0.73	0.73	0.36	0.73	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	245.36	3.74	2.08	1.80	1.80	0.62	0.35	0.83
Renal Epithelial Cells, donor1	11517-119H5	43.11	0.00	0.51	0.00	1.01	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	61.88	1.42	0.00	3.56	1.42	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	242.54	3.07	2.12	2.01	0.85	0.64	0.32	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	37.45	0.68	0.68	0.00	0.68	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	86.25	1.75	1.21	0.54	1.35	0.27	0.81	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	172.50	1.78	2.44	1.78	3.11	0.67	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	23.29	0.67	0.00	0.67	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	88.48	1.10	0.66	0.88	0.88	0.22	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	69.60	1.25	0.00	0.63	0.63	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	33.84	0.28	0.00	0.28	0.28	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	173.67	2.42	2.68	1.34	1.34	0.00	1.07	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	57.77	0.84	0.84	0.42	0.42	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	73.86	0.39	0.96	0.58	0.39	0.19	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	154.79	2.85	0.52	0.78	0.26	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	78.17	2.27	0.85	0.28	0.28	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	32.93	1.03	2.06	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	83.80	1.00	1.00	1.00	0.25	0.25	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	150.87	2.67	1.60	2.00	1.74	0.40	0.00	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	56.28	0.89	0.89	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	128.24	0.55	0.55	0.00	0.55	1.10	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	89.33	0.00	0.00	0.00	0.00	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	123.52	1.04	0.65	0.00	0.78	0.52	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	81.43	1.09	0.60	0.60	0.60	0.60	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	117.34	0.78	1.00	0.45	0.45	0.45	0.22	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	153.57	1.86	1.24	0.37	0.62	0.62	0.50	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	90.32	1.63	0.70	0.82	0.23	0.35	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	99.16	2.54	1.16	0.23	0.46	0.69	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	79.95	0.68	0.96	0.00	0.41	0.00	0.68	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	93.94	0.91	1.06	0.00	0.15	0.00	0.30	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	101.06	0.90	1.25	0.36	0.18	0.72	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	84.21	1.00	0.72	0.29	0.57	0.86	0.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	91.65	0.97	1.07	0.32	0.43	0.86	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	85.63	0.89	1.55	0.44	0.89	0.44	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	79.53	0.96	0.76	0.38	0.57	0.19	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	86.64	1.12	0.93	0.47	0.47	0.28	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	108.42	1.69	1.32	0.56	0.56	0.56	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	80.55	0.53	0.66	0.80	0.40	0.40	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	87.61	1.17	1.27	0.29	0.88	0.68	0.29	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	97.20	0.76	0.19	0.00	0.19	0.76	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	85.97	0.75	0.32	0.43	0.64	0.53	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	77.64	0.84	0.56	0.56	0.84	0.56	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	84.42	0.68	1.20	0.17	1.20	0.85	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	71.11	0.55	1.28	0.18	0.91	1.09	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	81.31	1.47	0.61	0.49	0.49	0.61	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	99.40	1.07	1.07	0.40	0.81	0.94	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	83.03	0.24	0.71	0.24	0.94	0.47	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	79.76	0.60	0.40	0.00	0.20	0.40	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	86.29	1.40	1.64	0.70	0.47	1.17	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	86.05	1.04	1.66	0.21	1.24	0.83	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	86.94	1.33	0.66	0.66	0.88	1.33	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	75.20	2.09	1.25	0.63	0.42	0.84	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	84.65	1.21	1.08	0.94	0.67	1.21	0.54	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	83.10	1.02	0.68	0.68	0.85	1.19	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	83.09	1.16	1.16	1.54	0.39	0.58	0.39	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	84.42	0.34	0.86	0.86	0.86	1.38	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	85.04	0.96	1.37	0.41	0.82	0.96	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	79.62	1.64	0.99	0.33	0.99	0.49	0.33	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	76.01	1.02	0.68	0.17	0.17	0.00	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	103.87	1.18	1.18	0.30	0.15	0.30	0.00	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	72.77	0.00	1.07	1.07	0.27	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	70.79	0.55	0.55	0.14	0.28	0.14	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	86.91	1.43	1.19	0.48	0.24	0.00	1.19	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	100.17	0.81	0.20	0.40	0.60	0.60	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	80.52	1.04	0.57	0.47	0.75	0.57	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	77.91	1.05	1.40	0.35	0.00	0.35	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	64.07	0.60	1.81	0.60	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	81.63	0.98	1.10	0.12	0.49	0.61	1.10	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	116.59	1.31	0.73	1.16	1.02	0.73	1.16	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	88.22	1.83	0.00	0.61	0.61	0.61	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	81.38	1.81	0.60	0.60	0.60	0.60	1.51	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	93.87	1.13	0.45	0.00	0.45	0.00	0.68	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	81.47	1.20	1.80	0.60	0.60	0.90	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	96.11	0.59	0.35	0.12	0.00	0.83	0.71	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	78.76	0.64	0.64	0.21	0.21	0.00	0.21	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	79.33	1.20	0.60	0.00	1.80	0.60	0.60	0.60
Schwann Cells, donor1	11498-119F4	57.17	0.56	1.32	0.19	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	132.69	6.80	6.80	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	154.45	2.85	1.10	1.10	0.88	0.44	0.00	0.66
Sebocyte, donor1	11220-116B5	580.09	8.22	5.48	4.38	2.19	1.10	0.55	0.55
Sebocyte, donor2	11301-117B5	203.12	4.60	3.22	3.22	1.84	0.46	0.92	0.00
Sebocyte, donor3	11378-118B1	145.31	3.50	3.92	1.44	1.24	0.00	0.00	0.21
Sertoli Cells, donor1	11255-116F4	268.37	1.66	6.63	4.97	0.00	4.97	1.66	1.66
Sertoli Cells, donor2	11333-117F1	107.33	2.82	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	110.06	2.38	1.06	0.44	0.62	0.62	0.09	0.62
Skeletal Muscle Cells, donor2	11358-117H8	23.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	118.72	4.18	0.84	0.84	1.67	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	149.40	1.73	2.04	0.79	0.63	0.63	0.31	0.47
Skeletal Muscle Cells, donor5	11455-119A6	129.62	2.23	1.93	1.04	1.19	0.15	0.59	0.74
Skeletal Muscle Cells, donor6	11459-119B1	176.68	1.85	2.77	1.08	0.92	0.15	0.77	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	225.55	2.65	1.89	0.63	0.50	0.50	0.38	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	146.11	3.57	1.71	1.43	1.14	0.00	0.71	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	198.42	2.88	2.98	2.38	1.09	0.30	0.60	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	130.67	2.36	1.10	0.93	0.51	1.10	0.34	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	84.68	1.45	1.45	0.72	0.72	0.00	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	99.35	1.38	0.83	0.55	0.28	0.55	0.83	0.69
Skin - palm, donor1	10286-104F7	69.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	124.84	1.87	1.44	2.31	2.59	1.01	0.58	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	237.19	0.00	0.00	3.27	3.27	2.45	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	126.19	1.69	0.91	1.17	2.08	0.39	0.91	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	233.53	3.06	2.64	2.64	2.22	1.11	0.56	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	162.88	1.83	3.52	1.97	2.81	0.56	1.41	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	358.19	2.75	1.48	2.11	1.90	1.06	2.54	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	133.49	2.85	3.07	2.17	2.10	1.05	0.30	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	195.03	2.78	2.78	1.54	2.16	1.54	0.93	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	231.00	3.56	2.00	1.56	2.22	1.56	1.11	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	245.12	1.76	2.35	1.76	2.94	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	192.70	5.08	1.99	0.88	1.77	0.88	0.44	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	304.79	2.76	2.36	1.18	1.97	1.58	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	224.04	1.55	1.55	3.09	2.32	2.32	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	64.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	321.78	5.32	3.33	1.73	2.53	2.13	1.33	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	172.00	2.44	1.33	0.66	1.77	1.11	0.66	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	269.38	6.91	4.35	1.54	1.79	2.18	1.79	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	214.56	2.60	0.98	0.98	0.33	0.98	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	264.91	5.32	1.18	1.77	1.48	2.95	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	198.03	3.56	1.99	2.42	0.85	1.71	1.00	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	36.28	0.81	0.33	0.65	0.00	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	84.33	1.22	0.30	1.83	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	171.74	2.02	2.02	1.01	1.01	0.51	0.51	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	153.02	0.00	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	151.16	3.81	2.86	0.48	0.48	0.00	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	211.04	2.36	1.92	1.62	0.88	1.33	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	160.35	1.51	1.51	0.86	1.29	0.00	0.65	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	182.31	2.31	2.10	1.15	1.26	0.21	0.52	1.15
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	306.11	5.57	2.47	1.55	2.01	0.93	0.46	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	191.86	3.23	2.16	4.31	3.23	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	170.95	1.49	3.59	1.49	1.49	0.90	2.09	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	45.41	0.00	0.68	0.34	0.68	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	142.29	1.26	0.31	0.47	0.39	0.55	0.24	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	243.25	6.14	3.32	3.52	1.71	1.71	0.50	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	171.57	2.50	1.14	1.14	1.37	1.37	0.91	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	152.16	1.81	1.21	1.21	1.21	1.81	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	273.40	3.44	2.91	1.32	0.26	0.26	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	234.23	3.60	1.33	0.93	0.80	1.20	0.53	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	132.98	2.38	0.88	0.88	0.63	0.75	0.25	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	136.98	2.03	0.76	1.27	0.51	0.76	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	365.93	4.67	4.22	2.56	2.41	1.96	3.02	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	121.53	5.25	0.75	0.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	310.13	16.80	7.75	3.88	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	169.75	1.40	1.86	0.93	0.93	0.93	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	143.89	0.50	1.01	4.04	1.01	1.01	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	162.65	4.70	1.25	1.25	1.88	0.94	0.94	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	58.70	0.88	0.29	0.29	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	287.66	4.17	2.33	3.17	1.42	0.67	0.25	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	112.59	0.93	0.93	0.47	0.47	0.00	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	421.68	6.48	6.19	2.59	3.45	5.18	1.73	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	284.79	5.86	6.12	3.82	2.29	1.27	0.25	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	177.88	3.57	3.20	0.19	1.88	1.32	0.56	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	303.80	4.05	2.10	1.12	0.70	0.70	0.70	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	276.84	3.35	2.09	1.76	2.18	1.01	1.17	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	17.62	0.00	0.95	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	469.75	6.36	5.14	4.40	4.40	4.89	1.96	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	302.04	4.20	5.52	1.33	1.77	3.76	2.21	1.99
Smooth Muscle Cells - Uterine, donor3	11466-119B8	216.80	2.63	2.05	0.88	2.63	0.29	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	68.80	0.78	0.78	0.78	0.58	0.19	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	127.73	1.06	1.06	1.06	1.06	0.00	0.79	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	175.19	1.49	0.00	0.74	1.12	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	165.30	0.72	2.16	0.72	1.80	1.08	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	138.83	2.27	0.85	1.42	2.84	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	169.36	1.97	1.18	1.58	0.79	0.39	0.39	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	97.26	1.52	0.51	0.76	1.78	0.51	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	77.47	0.00	1.20	0.00	0.40	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	69.39	1.25	0.84	0.42	0.42	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	77.00	0.92	0.92	0.46	0.46	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	309.37	5.72	3.87	1.35	1.68	4.71	1.35	0.50
Synoviocyte, donor2	11368-117I9	94.20	2.51	1.51	0.50	0.50	1.01	0.34	0.34
Synoviocyte, donor3	11440-118H9	72.83	1.34	1.79	0.00	0.00	0.67	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	69.32	0.71	1.07	0.36	0.36	0.71	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	33.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	39.36	0.23	0.00	0.00	0.23	0.23	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	200.07	2.72	1.22	1.72	0.86	0.86	0.86	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	124.86	3.09	1.55	0.39	0.77	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	101.93	1.72	0.57	0.57	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	157.10	3.20	1.60	1.85	2.83	0.98	0.25	0.86
Urethra, donor2	10319-105A4	66.54	0.00	0.00	0.00	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	124.06	0.27	2.13	1.86	1.86	1.06	1.06	0.00
Urothelial Cells, donor2	11600-120H7	75.31	1.60	1.20	2.80	2.00	1.20	2.80	0.40
Urothelial Cells, donor3	11681-122H7	57.76	0.46	1.15	1.15	1.15	1.15	0.46	0.00
Urothelial cells, donor0	11216-116B1	485.02	4.46	6.46	4.46	5.13	0.67	1.34	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	680.68	8.90	15.13	23.13	31.14	2.67	9.79	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	626.17	12.87	15.73	28.59	28.59	0.00	7.15	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	332.68	8.90	10.27	22.59	18.48	2.74	2.05	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	417.68	7.23	5.17	22.38	12.40	1.72	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	409.62	5.23	7.55	16.85	8.72	0.58	2.91	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	586.22	5.21	10.41	27.07	33.32	3.12	4.16	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	598.40	11.93	8.26	21.11	26.62	0.92	11.93	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	269.30	8.22	12.78	25.56	9.13	0.00	7.30	2.74
Wilms' tumor cell line:G-401	10809-111A8	115.84	0.99	1.73	0.62	0.37	0.74	0.49	0.99
Wilms' tumor cell line:HFWT	10597-108E3	52.80	0.88	1.76	0.88	0.88	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	98.60	3.07	0.28	0.56	0.84	0.00	0.28	0.56
achilles tendon, donor2	10292-104G4	105.39	0.00	0.00	2.07	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	106.06	0.51	0.51	0.51	0.25	0.00	1.27	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	107.73	1.39	0.93	0.23	0.23	0.23	0.93	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	127.85	4.39	1.66	0.47	0.47	0.12	0.36	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	191.84	1.09	2.99	1.90	0.82	1.36	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	102.31	1.41	1.12	2.25	2.25	0.56	0.84	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	253.35	3.17	3.17	6.13	4.23	3.17	5.50	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	164.96	1.09	1.36	3.27	2.18	0.00	0.82	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	130.43	1.32	3.08	3.97	1.32	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	144.97	1.23	1.63	0.82	0.82	0.00	0.82	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	171.63	3.49	0.39	1.16	0.78	0.78	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	124.20	2.94	0.74	0.92	0.92	0.55	0.37	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	140.42	0.00	0.00	0.00	3.90	0.00	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	161.74	4.42	3.02	3.49	2.79	0.46	0.93	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	206.09	2.07	1.29	3.11	1.55	0.78	3.37	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	186.16	3.21	2.05	2.05	3.21	0.88	1.46	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	154.30	4.65	0.93	2.79	0.93	0.46	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	190.41	2.06	1.65	5.35	4.52	0.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1006.49	13.81	11.66	14.73	11.05	4.60	0.92	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	3956.44	52.49	26.46	20.91	20.91	17.92	6.83	6.83
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	4738.05	61.87	33.97	19.71	28.51	20.62	3.94	4.25
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	4417.91	61.38	32.74	23.35	26.72	18.05	3.13	7.70
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	153.91	2.90	1.34	5.12	3.34	1.11	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	134.75	4.00	3.34	2.00	1.67	1.00	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	85.48	0.00	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	293.80	5.27	3.01	7.53	4.14	2.64	2.26	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	122.99	1.31	2.62	1.74	1.31	0.87	3.49	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	99.35	0.00	1.87	7.50	3.75	1.87	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	76.54	0.24	0.47	0.24	0.24	0.24	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	208.33	3.57	2.64	1.86	2.95	2.33	0.00	0.62
adipose, donor1	10184-103D4	228.70	3.52	1.76	0.00	0.00	0.00	1.76	4.69
adipose, donor2	10185-103D5	40.55	0.81	0.00	0.00	0.00	0.00	0.00	0.81
adipose, donor3	10186-103D6	142.41	4.90	1.09	0.00	0.00	0.00	0.54	0.82
adipose, donor4	10187-103D7	230.56	6.07	0.87	0.00	0.87	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	112.68	5.21	3.00	2.53	0.79	0.47	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	223.86	1.07	1.07	1.60	1.47	1.07	1.60	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	150.42	5.00	1.43	0.36	0.00	0.36	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	172.03	3.48	2.55	1.16	1.62	3.71	0.70	0.46
amniotic membrane cells, donor2	12236-129G4	122.73	2.37	3.38	0.34	0.68	1.35	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	99.58	2.95	2.95	0.00	0.88	0.59	0.00	0.00
amygdala - adult, donor10196	10167-103B5	129.25	4.74	2.37	2.37	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	122.27	3.65	2.43	2.43	0.81	0.61	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	68.75	2.58	4.20	3.55	2.26	0.00	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	168.20	2.42	2.42	2.16	1.91	0.00	0.25	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	105.46	1.10	0.88	0.88	1.10	0.66	2.21	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	73.49	0.67	0.67	0.33	0.00	0.33	0.33	0.00
aorta, adult, pool1	10052-101G7	152.20	1.77	2.75	1.37	1.37	1.96	0.78	0.39
appendix, adult	10189-103D9	155.25	1.16	1.55	1.16	2.72	1.16	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	59.84	0.34	0.34	0.00	0.00	0.00	0.34	0.34
artery, adult	10190-103E1	73.37	1.36	0.00	0.00	2.72	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	567.73	4.93	8.98	2.61	2.75	12.75	3.48	0.87
b cell line:RPMI1788	10427-106D4	108.11	0.74	0.45	0.00	0.15	0.30	0.89	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	432.82	6.94	4.99	2.22	3.05	3.05	1.39	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	203.62	2.58	1.29	0.69	0.89	0.99	0.50	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	39.67	1.00	0.33	0.67	0.17	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	101.78	1.68	0.56	1.12	0.56	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	164.27	1.63	1.63	2.17	1.09	0.22	0.22	0.43
blood, adult, pool1	10053-101G8	208.17	2.21	2.21	15.50	0.00	0.00	6.64	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	200.39	2.57	0.00	2.57	2.57	0.86	0.86	0.00
bone marrow, adult	10192-103E3	153.86	3.37	2.70	2.02	2.70	2.02	0.67	0.00
brain, adult, donor1	10084-102B3	65.60	1.03	0.00	0.00	5.13	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	125.72	5.01	2.12	1.45	1.00	0.11	0.33	1.22
brain, fetal, pool1	10085-102B4	61.44	2.67	2.67	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	58.47	1.65	1.32	0.66	0.99	0.33	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	194.10	1.00	1.00	0.62	1.12	0.50	1.50	0.12
breast, adult, donor1	10080-102A8	75.76	0.63	0.63	1.26	2.53	0.00	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	94.01	1.02	0.38	0.38	0.64	0.13	0.13	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	92.77	0.93	0.62	0.00	0.62	0.31	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	238.97	3.68	1.84	1.84	1.61	2.07	0.46	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	87.39	1.94	0.97	0.24	0.24	0.24	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	78.05	0.47	0.47	0.47	0.00	0.00	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	105.01	1.53	1.20	0.88	1.42	0.98	0.66	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	38.34	0.63	0.63	0.32	0.32	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	108.07	2.13	2.13	0.27	0.80	0.00	0.27	1.33
caudate nucleus - adult, donor10196	10177-103C6	105.92	5.76	3.45	2.30	2.30	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	107.26	3.68	1.17	2.84	2.01	0.33	0.00	0.50
caudate nucleus, adult, donor10258	10379-105H1	103.92	1.53	1.53	6.88	1.53	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	69.22	4.39	2.20	2.56	3.66	0.73	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	99.05	2.91	2.91	2.91	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	97.57	2.35	0.85	1.07	0.64	0.00	0.21	0.21
cerebellum, adult, pool1	10083-102B2	42.43	1.03	1.38	0.34	0.69	0.34	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	49.82	1.66	0.83	2.49	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	104.13	2.77	2.77	1.51	1.26	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	49.70	0.73	0.73	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	105.39	2.88	2.16	0.43	0.29	0.00	0.00	0.43
cervical cancer cell line:ME-180	10553-107I4	104.40	1.66	1.33	0.33	0.66	0.83	0.33	0.17
cervix, adult, pool1	10013-101C4	155.18	5.04	1.05	1.78	1.15	0.63	0.73	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	349.46	6.13	5.71	0.84	2.23	1.81	1.25	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	67.93	1.31	5.23	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	185.67	3.73	1.74	0.62	1.12	0.62	0.25	0.75
choriocarcinoma cell line:SCH	10785-110H2	104.48	0.99	1.11	0.37	0.49	0.62	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	70.68	0.71	0.95	0.24	0.24	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	158.70	2.56	1.14	1.14	0.57	1.71	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	356.76	5.47	3.98	0.80	2.09	1.49	0.50	1.89
chorionic membrane cells, donor3	12240-129G8	189.02	5.49	3.85	0.55	2.20	1.10	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	82.80	0.00	1.01	3.03	1.01	0.00	3.03	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	122.56	2.88	2.31	4.61	2.69	0.77	0.38	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	150.36	1.27	0.84	2.11	1.06	0.21	2.53	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	111.19	0.26	0.51	0.51	0.77	0.51	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	100.62	0.73	0.48	0.48	0.97	0.24	1.21	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	132.55	1.83	1.22	1.02	0.20	0.20	0.61	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	88.04	0.88	0.29	0.29	0.00	0.88	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	196.77	2.35	1.82	3.91	1.30	2.09	1.82	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	260.35	4.11	1.14	1.14	1.37	0.69	0.00	0.91
clear cell carcinoma cell line:TEN	10636-108I6	119.72	2.60	1.39	0.52	0.17	0.17	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	104.70	2.20	0.00	0.37	0.55	0.18	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	96.16	0.76	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	82.11	2.38	2.38	1.19	2.38	0.00	0.00	2.38
colon, adult, pool1	10014-101C5	164.39	3.53	1.06	0.94	0.82	1.29	0.12	0.12
colon, fetal, donor1	10070-101I7	64.89	3.09	1.24	0.62	1.24	3.09	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	22.92	0.00	4.58	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	93.49	0.00	0.00	0.00	0.85	3.82	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	118.03	0.75	0.60	0.15	0.45	3.02	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	128.18	1.55	0.85	0.14	0.00	3.67	0.42	0.00
corpus callosum, adult, pool1	10042-101F6	191.49	8.51	3.65	1.44	1.55	0.11	0.77	0.33
cruciate ligament, donor2	10295-104G7	88.34	3.24	1.62	4.05	1.62	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	45.75	2.41	2.41	1.61	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	113.27	3.36	2.16	3.60	2.88	0.00	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	58.32	0.46	1.15	0.00	1.15	0.00	2.07	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	105.65	3.08	1.28	0.77	1.28	0.77	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	177.89	3.85	2.41	0.96	0.96	0.72	0.48	0.24
ductus deferens, adult	10196-103E7	85.71	3.99	1.50	1.00	0.50	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	59.05	0.00	2.88	0.00	0.00	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	114.03	2.21	2.21	1.47	0.74	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	229.84	4.46	2.56	3.55	2.40	0.91	1.24	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	54.63	0.44	0.44	0.44	0.00	0.00	0.89	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	116.07	2.44	0.72	0.29	1.00	0.00	0.29	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	58.58	0.00	1.23	1.23	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	95.66	0.91	1.51	0.00	0.30	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	87.07	0.62	1.23	0.31	0.93	0.93	0.62	0.31
embryonic pancreas cell line:2C6	10603-108E9	65.67	1.31	1.31	0.00	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	81.45	0.34	1.68	0.00	0.67	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	279.65	5.07	3.44	1.99	2.90	5.80	2.36	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	115.30	1.13	1.13	1.45	0.48	1.61	0.16	0.32
epidermoid carcinoma cell line:A431	10426-106D3	197.97	1.78	1.22	0.89	1.22	1.45	1.33	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	211.28	2.53	1.98	1.98	1.65	0.55	0.77	0.77
epididymis, adult	10197-103E8	102.35	1.47	0.42	0.63	1.05	0.00	0.21	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	290.78	3.73	3.73	0.89	1.06	3.73	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	56.23	0.39	0.00	0.39	1.18	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	101.56	0.79	1.18	0.13	0.52	1.31	0.00	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	99.60	2.17	0.98	0.39	0.30	0.49	0.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	102.17	1.57	2.02	0.45	0.34	1.68	0.67	0.45
esophagus, adult, pool1	10015-101C6	183.58	2.44	1.81	2.02	0.64	0.85	0.64	1.06
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	106.83	1.75	0.75	0.13	0.00	0.25	0.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	70.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	63.13	4.21	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	20.84	0.00	2.98	2.98	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	72.23	1.15	0.00	2.29	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	55.38	0.00	2.91	1.46	0.00	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	75.76	2.80	0.51	1.53	0.76	0.00	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	184.77	1.03	1.92	0.51	0.38	0.38	0.64	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	167.62	1.90	1.42	0.95	0.95	1.19	0.00	0.47
frontal lobe, adult, pool1	10040-101F4	142.80	5.82	1.60	1.31	0.75	0.75	0.28	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	168.74	1.50	1.20	0.30	0.30	2.40	1.20	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	167.60	2.01	1.10	0.55	0.91	0.18	0.27	0.00
gall bladder, adult	10198-103E9	121.20	2.17	1.93	0.72	1.21	0.24	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	302.79	0.54	1.07	1.07	2.68	3.76	24.16	0.00
gamma delta positive T cells, donor2	11938-126A3	296.93	1.49	2.61	2.99	3.36	3.36	16.43	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	157.99	2.75	2.32	1.27	1.69	0.63	0.63	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	105.02	3.67	0.77	1.93	1.74	0.00	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	147.40	3.44	1.15	1.15	0.98	0.33	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	42.10	0.00	0.92	1.83	0.00	0.00	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	76.76	0.69	0.69	0.46	0.00	0.23	0.23	0.46
giant cell carcinoma cell line:LU65	10487-107B1	125.64	2.29	1.49	0.34	0.57	0.46	0.69	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	137.02	1.82	1.12	0.42	0.98	0.56	0.14	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	58.61	1.75	0.50	1.00	0.50	0.50	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	134.26	2.85	1.79	0.95	0.42	0.21	1.06	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	149.43	2.25	1.54	1.12	0.42	0.56	0.56	0.00
glioblastoma cell line:T98G	10485-107A8	132.23	2.21	0.44	0.33	0.55	0.22	0.55	0.22
glioma cell line:GI-1	10413-106B8	150.25	2.64	1.46	1.17	0.59	0.29	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	74.35	1.46	2.19	2.19	0.73	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	170.13	5.13	3.42	3.66	1.95	0.73	0.00	0.49
globus pallidus, adult, donor10258	10367-105F7	104.06	4.11	4.11	4.11	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	72.48	3.20	2.66	1.60	2.66	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	39.15	2.45	4.89	4.89	0.00	0.00	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	120.21	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	104.53	0.00	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	144.96	1.92	2.56	2.24	0.96	0.32	0.32	0.64
hIPS +CCl2, biol_rep1	14383-156B9	94.12	0.92	0.92	0.92	0.92	0.00	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	113.86	1.83	0.91	0.00	0.00	0.00	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	76.00	0.64	0.00	0.00	0.64	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	47.43	0.00	0.00	1.44	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	74.07	0.69	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	81.66	0.00	2.21	2.21	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	109.19	1.44	1.44	2.30	0.29	1.15	0.86	0.00
heart - mitral valve, adult	10205-103F7	78.03	2.09	1.79	2.39	2.39	0.30	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	90.99	3.40	0.78	1.57	2.09	0.52	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	76.60	1.67	1.67	1.67	0.83	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	52.24	0.61	1.43	0.61	0.41	0.61	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	43.01	0.00	0.85	1.70	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	68.53	2.07	2.07	2.30	1.38	0.46	0.23	0.00
heart, fetal, pool1	10046-101G1	81.84	0.82	0.62	1.13	1.23	0.51	0.62	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	217.82	2.47	1.54	0.93	2.16	1.23	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	47.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	105.74	1.55	1.10	0.33	0.22	0.33	1.33	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	124.89	1.82	1.21	0.12	0.49	0.24	1.09	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	132.88	1.11	1.62	0.30	0.40	0.30	0.91	0.20
hepatoma cell line:Li-7	10484-107A7	63.06	0.44	0.78	0.11	0.11	0.56	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	116.88	1.21	1.11	0.70	0.80	0.20	1.91	0.30
hippocampus - adult, donor10196	10169-103B7	87.06	4.73	0.00	0.95	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	111.03	1.63	1.63	2.04	2.25	0.20	0.20	0.41
hippocampus, adult, donor10258	10374-105G5	70.21	1.49	0.00	1.00	1.49	0.50	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	45.12	3.88	0.70	1.76	2.11	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	164.79	1.22	1.22	0.00	1.22	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	80.31	0.98	0.98	0.39	0.39	0.20	0.59	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	90.89	0.25	0.25	0.25	0.00	0.00	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	66.54	0.56	0.00	0.00	0.00	0.00	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	79.53	1.29	0.26	0.00	0.00	0.00	0.00	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	93.00	0.38	0.00	0.38	0.38	0.00	0.38	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	80.00	2.34	0.88	0.58	0.29	0.29	0.88	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	71.52	1.51	0.65	0.86	0.22	0.22	0.43	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	60.06	1.67	0.83	0.42	0.00	0.00	0.42	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	122.90	2.60	0.95	0.24	0.95	0.71	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	85.02	1.29	0.80	0.00	0.32	0.16	0.48	2.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	103.02	0.67	0.67	0.00	0.00	0.67	0.67	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	85.75	1.25	0.63	0.63	0.63	0.16	0.78	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	92.36	0.98	1.97	0.49	0.00	0.49	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	138.77	0.87	1.75	0.87	0.87	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	94.12	1.15	0.76	0.19	0.00	0.00	0.57	2.48
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	99.86	0.44	0.44	0.87	0.87	0.44	0.44	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	94.95	2.00	1.00	1.00	0.00	0.00	1.50	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	73.10	1.13	0.57	0.00	0.00	0.00	0.38	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	76.85	0.91	0.45	0.00	0.45	0.00	0.45	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	63.59	1.57	0.00	0.00	0.94	0.00	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	93.74	1.80	0.65	0.65	0.16	0.16	0.33	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	91.45	1.45	1.16	0.00	0.29	0.29	0.29	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	71.44	0.00	0.90	0.00	0.60	0.60	0.30	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	95.51	1.29	0.18	0.37	0.18	0.00	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	89.01	0.57	1.14	0.57	0.00	0.29	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	146.58	0.82	1.63	0.82	0.41	0.00	1.63	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	111.26	1.06	1.76	0.70	0.70	0.00	0.00	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	77.28	1.27	0.32	0.32	0.63	0.32	0.32	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	93.21	0.91	0.61	0.00	0.61	0.00	0.30	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	71.36	1.03	0.52	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	60.44	0.66	1.33	0.66	0.66	0.00	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	66.19	0.26	0.51	0.00	0.00	0.00	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	116.06	0.77	1.02	1.02	0.26	0.51	0.26	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	102.23	3.03	0.76	0.00	0.76	0.00	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	101.15	0.67	0.00	0.67	0.67	0.00	0.34	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	88.63	1.45	0.24	0.00	0.48	0.00	0.24	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	99.83	0.45	0.45	0.00	0.45	0.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	92.68	0.49	1.95	0.00	0.98	1.46	0.00	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	99.94	1.22	0.61	0.31	0.00	0.00	0.31	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	816.56	6.51	3.25	0.00	0.00	3.25	0.00	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	133.37	0.99	0.66	0.33	0.33	0.00	0.00	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	74.98	2.19	1.09	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	76.36	1.45	0.00	0.00	0.36	0.00	0.36	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	62.28	1.42	0.36	0.00	0.00	0.00	0.00	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	79.96	3.58	1.19	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	163.73	2.98	1.08	0.54	0.41	0.14	0.41	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	84.59	1.62	1.08	0.27	0.81	0.00	0.54	2.96
immature langerhans cells, donor1	11904-125F5	249.89	3.39	1.70	2.18	1.94	0.48	2.42	0.00
immature langerhans cells, donor2	11905-125F6	150.51	2.38	1.58	1.58	0.00	0.00	3.96	0.00
insula, adult, pool1	10039-101F3	156.90	6.15	1.61	2.18	1.61	1.04	0.19	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	73.16	1.30	1.30	0.00	0.00	0.33	0.98	0.33
kidney, adult, pool1	10017-101C8	191.84	1.80	1.60	1.10	1.30	1.30	1.10	0.40
kidney, fetal, pool1	10045-101F9	114.66	3.32	1.13	1.41	0.21	0.50	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	297.53	6.25	3.41	2.41	1.70	0.99	1.14	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.91	1.11	1.94	0.14	0.41	0.00	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	85.14	1.65	0.73	0.73	0.55	0.18	0.00	0.18
left atrium, adult, donor1	10079-102A7	38.68	0.54	0.54	1.09	0.00	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	34.89	1.52	0.00	2.53	2.02	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	293.04	4.92	9.58	12.04	9.58	1.64	13.13	1.37
leiomyoma cell line:10964C	10569-108B2	157.71	3.95	2.87	1.08	1.44	0.72	0.72	1.44
leiomyoma cell line:15242A	10570-108B3	218.48	5.43	3.80	3.80	3.26	1.63	2.17	0.54
leiomyoma cell line:15425	10571-108B4	214.16	4.86	0.97	2.43	1.94	1.21	0.49	2.67
leiomyosarcoma cell line:Hs 5.T	10722-110A2	152.38	6.35	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	87.83	2.09	0.00	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	219.71	2.13	1.18	1.65	2.01	0.71	1.42	0.12
liposarcoma cell line:KMLS-1	10782-110G8	87.01	1.25	1.41	0.31	0.78	0.31	0.47	0.31
liposarcoma cell line:SW 872	10726-110A6	122.20	1.22	0.85	0.61	0.97	0.61	1.10	0.24
liver, adult, pool1	10018-101C9	134.35	1.94	0.81	0.49	0.32	1.30	0.49	0.81
liver, fetal, pool1	10086-102B5	31.98	0.00	0.94	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	73.64	2.77	1.17	1.02	1.02	0.00	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	124.02	2.95	1.85	1.85	0.55	0.74	0.18	0.37
locus coeruleus, adult, donor10258	10375-105G6	64.05	2.26	0.85	0.85	1.13	0.28	0.28	0.85
locus coeruleus, newborn, donor10223	10362-105F2	117.77	1.26	0.84	1.26	3.36	0.42	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	65.74	1.11	0.42	0.28	0.42	0.42	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	178.56	2.07	2.07	0.69	1.38	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	213.81	2.24	1.32	0.92	0.79	1.85	1.98	0.66
lung, adult, pool1	10019-101D1	203.42	2.01	1.42	4.49	3.07	0.71	0.24	0.95
lung, fetal, donor1	10068-101I5	168.96	4.28	1.14	1.14	2.85	1.14	0.57	0.57
lung, right lower lobe, adult, donor1	10075-102A3	87.52	0.92	0.92	0.46	0.46	2.29	0.46	0.92
lymph node, adult, donor1	10077-102A5	133.01	0.47	1.89	1.42	1.89	0.47	1.89	0.95
lymphangiectasia cell line:DS-1	10727-110A7	70.79	1.97	0.44	1.32	0.00	0.00	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	110.63	1.36	0.75	0.30	0.45	0.45	3.92	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	121.48	0.00	0.85	0.00	0.00	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	137.19	4.00	2.22	1.33	0.44	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	162.49	3.74	1.25	1.45	1.45	1.45	0.21	0.21
mature adipocyte, donor3	12233-129G1	144.37	3.79	0.24	0.71	0.24	0.71	0.24	0.00
mature adipocyte, donor4	12234-129G2	148.72	3.95	1.58	0.53	0.79	0.00	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	143.19	3.34	1.19	0.71	1.19	0.48	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	95.88	4.51	1.13	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	100.05	3.31	2.76	1.84	0.55	0.00	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	57.50	2.86	0.64	1.59	0.95	0.32	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	181.26	4.26	2.99	2.56	2.56	0.00	0.43	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	77.96	2.19	1.52	0.68	0.84	0.17	0.34	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	106.75	3.18	0.85	1.91	1.70	0.21	0.00	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	0.00	0.00	0.00	3.85	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	588.50	14.35	0.00	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	72.50	3.95	1.79	1.08	2.51	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	61.00	4.54	1.95	0.00	1.30	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	129.26	4.18	3.10	1.55	2.17	0.31	0.46	0.31
medulla oblongata, adult, pool1	10038-101F2	147.83	4.65	2.29	1.31	1.55	0.49	0.41	0.24
medulla oblongata, newborn, donor10223	10361-105F1	71.87	2.43	1.39	1.39	2.08	0.35	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	84.14	1.11	1.33	0.66	0.44	0.00	0.00	0.44
medulloblastoma cell line:ONS-76	10759-110E3	124.96	3.42	2.69	1.96	1.71	0.37	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	198.80	2.73	2.73	1.44	2.30	0.86	4.46	1.29
melanoma cell line:G-361	10465-106H6	100.98	1.09	1.90	0.00	0.00	0.54	0.54	0.81
meningioma cell line:HKBMM	10691-109F7	117.05	0.90	1.81	0.72	1.27	0.18	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	71.37	1.76	0.88	0.00	0.00	0.00	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	129.35	1.04	1.04	0.26	0.26	0.52	0.78	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	268.82	3.38	4.14	0.61	1.99	1.69	0.46	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	179.96	1.64	3.82	0.18	0.91	0.55	0.73	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	174.34	3.73	2.07	1.24	0.83	1.24	1.24	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	181.21	3.23	3.09	0.84	1.97	0.56	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	149.63	2.89	3.08	0.39	2.50	0.39	0.00	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	99.25	2.78	1.39	0.00	0.69	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	106.76	2.40	1.54	0.34	0.69	0.17	0.69	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	165.05	4.14	2.42	0.69	1.38	1.27	0.35	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	222.57	4.91	3.18	0.93	0.93	1.46	1.33	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	287.37	4.05	2.84	2.03	3.11	1.35	2.03	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	330.62	3.84	5.69	1.71	1.99	1.56	2.42	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	101.44	0.99	0.99	0.66	0.66	0.99	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	289.20	3.46	4.57	1.66	2.77	1.80	1.66	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	279.96	2.79	2.79	2.79	1.40	2.09	0.70	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	310.53	4.49	2.86	1.63	3.27	2.25	1.84	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	237.24	3.59	1.44	3.24	3.95	2.16	1.80	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	280.25	2.90	3.21	0.52	1.97	2.69	2.17	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	247.83	5.24	3.19	3.42	1.82	0.91	1.82	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	558.43	8.39	10.07	2.52	6.29	5.45	3.36	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	258.83	3.44	3.44	1.20	2.09	1.34	1.79	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	271.26	3.41	4.03	1.05	1.75	3.59	1.14	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	207.27	2.95	1.47	2.58	4.79	1.10	2.21	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	275.57	5.15	2.58	2.29	4.01	3.15	0.57	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	204.19	4.63	3.79	1.26	0.84	0.00	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	156.64	1.83	1.37	0.91	0.91	0.00	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	193.63	3.07	1.28	1.28	0.77	0.51	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	172.76	1.57	1.83	0.79	1.05	1.83	1.31	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	163.90	2.46	1.54	0.92	1.85	0.62	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	166.16	1.65	1.41	1.65	1.88	0.94	0.71	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	171.94	3.38	4.06	0.68	2.03	2.03	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	178.41	2.36	1.96	0.79	3.14	1.18	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	151.99	2.78	1.39	0.93	1.85	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	199.87	3.17	2.31	1.15	1.15	1.73	0.58	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	174.91	3.79	2.68	0.67	0.89	2.01	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	185.55	2.88	1.44	1.44	1.44	0.96	0.00	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	200.93	6.60	1.47	0.00	0.73	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	161.79	1.34	1.34	1.34	1.01	1.68	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	145.33	5.32	1.64	2.87	0.00	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	147.77	4.30	0.86	2.58	0.86	1.72	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	155.86	10.94	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	98.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	164.02	2.92	0.00	0.65	2.27	0.32	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	141.13	1.45	0.00	2.91	2.91	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	150.33	1.07	1.07	0.53	1.60	1.07	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	121.85	2.45	0.82	0.82	0.00	2.45	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	140.33	1.55	1.94	0.39	1.55	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	102.84	2.10	4.20	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	138.09	4.97	2.98	0.99	1.99	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	100.11	4.77	0.00	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	155.36	2.37	0.00	0.59	0.59	2.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	138.90	0.00	1.22	1.22	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	136.81	0.00	2.53	1.27	1.90	1.90	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	71.74	1.03	0.00	1.03	1.38	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	47.28	2.15	2.15	0.00	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	48.49	0.81	0.00	0.00	0.00	0.41	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	45.28	1.59	0.00	0.00	0.79	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	43.04	1.77	0.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	43.64	1.25	1.56	0.31	0.94	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	81.54	1.34	0.00	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	50.85	1.18	2.37	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	64.20	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	81.92	1.38	2.07	0.00	1.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	72.24	0.49	2.97	0.49	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	37.01	3.36	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	52.16	0.00	0.64	0.00	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	70.93	0.40	0.00	0.00	0.40	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	50.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	51.95	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	46.12	0.61	0.00	0.00	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	32.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	60.52	1.98	0.79	0.60	0.20	0.00	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	55.81	0.65	0.97	0.00	0.00	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	71.30	2.04	2.04	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	186.47	6.19	1.55	2.32	2.32	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	274.04	6.85	4.96	1.42	2.13	0.47	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	121.86	0.93	0.00	0.23	0.70	0.93	1.39	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	209.41	4.27	0.00	0.00	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	182.07	1.23	0.92	0.51	0.31	0.31	0.72	0.72
mesothelioma cell line:Mero-25	10850-111F4	46.07	0.23	0.23	0.45	0.68	0.00	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	234.21	4.16	1.71	1.71	2.93	0.98	0.49	0.73
mesothelioma cell line:Mero-48a	10852-111F6	283.21	5.31	4.43	1.77	1.99	2.44	0.00	0.44
mesothelioma cell line:Mero-82	10853-111F7	102.49	1.31	0.53	0.26	0.26	0.00	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	172.94	1.19	1.19	1.02	0.34	0.85	1.02	1.36
mesothelioma cell line:Mero-84	10855-111F9	69.01	2.27	0.25	0.00	0.25	2.53	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	98.14	2.48	0.83	0.21	0.21	0.83	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	186.35	2.48	1.82	2.15	2.15	0.33	0.17	0.50
mesothelioma cell line:NCI-H226	10846-111E9	147.15	1.45	1.27	0.18	1.27	1.09	0.54	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	147.08	2.05	0.68	0.85	1.20	0.17	0.51	0.34
mesothelioma cell line:NCI-H28	10845-111E8	148.35	3.05	2.04	1.02	0.76	0.25	0.25	0.51
mesothelioma cell line:No36	10857-111G2	55.78	0.65	0.00	0.33	1.30	0.00	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	132.22	2.44	0.54	1.08	0.81	0.81	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	744.85	4.61	2.11	2.11	2.11	2.30	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	487.48	2.32	1.47	1.47	1.71	1.10	0.24	0.49
migratory langerhans cells, donor3	11903-125F4	445.83	2.69	1.79	0.90	1.08	0.90	0.90	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	74.11	1.96	1.63	0.98	0.65	0.00	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	114.45	1.91	1.70	1.27	1.70	0.21	0.00	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	125.31	2.07	2.99	0.92	1.15	0.46	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	219.41	0.76	0.95	0.19	0.57	2.85	2.85	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	226.92	5.17	2.77	0.92	1.85	1.11	1.48	0.18
myeloma cell line:PCM6	10474-106I6	219.21	2.37	1.58	0.79	0.20	2.17	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	68.48	0.51	0.51	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	144.55	2.75	2.55	1.77	1.57	0.20	0.59	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	126.02	1.78	3.34	1.56	2.34	0.45	0.33	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	121.34	2.43	1.32	1.62	1.47	1.03	0.15	0.29
nasal epithelial cells, donor2	12227-129F4	199.82	4.42	1.66	1.10	2.76	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	39.57	0.69	0.23	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	87.93	1.87	1.31	0.75	0.75	0.56	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	111.35	2.74	1.90	0.21	0.21	0.00	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	46.22	0.56	0.37	0.19	0.00	0.00	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	55.99	0.71	0.71	0.00	0.24	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	46.72	1.27	0.48	0.00	0.00	0.00	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	62.79	0.20	0.20	0.00	0.81	0.00	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	27.97	0.64	0.64	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	173.01	1.86	1.60	0.53	1.86	1.33	1.06	0.00
neutrophil PMN, donor1	12133-128D9	163.62	14.87	0.00	0.00	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	398.42	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	520.88	0.00	18.94	18.94	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	210.39	2.54	0.85	0.00	0.68	0.00	0.68	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	81.65	2.40	1.60	0.80	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	112.85	2.24	1.60	0.64	0.96	0.00	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	174.74	1.58	2.63	0.79	1.05	0.53	0.79	1.05
nucleus accumbens, adult, pool1	10037-101F1	163.11	5.72	2.62	3.94	1.69	0.28	0.19	0.09
occipital cortex - adult, donor10196	10172-103C1	90.66	0.00	0.00	2.06	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	108.96	3.22	2.42	1.34	1.07	0.00	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	77.52	1.82	0.73	4.00	2.18	0.00	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	75.31	4.20	2.62	0.79	0.26	0.00	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	57.50	0.43	0.43	0.00	0.43	0.86	0.00	0.00
occipital pole, adult, pool1	10036-101E9	96.98	3.63	1.97	1.18	0.63	0.08	0.55	0.00
olfactory region, adult	10195-103E6	88.84	3.63	1.72	1.15	0.57	0.38	0.19	0.00
optic nerve, donor1	10277-104E7	100.05	4.00	0.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	101.95	1.48	0.34	0.23	0.34	0.46	0.11	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	115.54	7.69	3.30	1.65	0.96	0.41	0.41	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	131.40	1.02	1.69	0.68	0.34	0.51	1.02	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	92.64	1.96	1.85	1.16	0.81	0.35	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	162.56	3.53	1.47	0.59	1.18	1.18	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	228.91	1.87	2.80	0.00	1.87	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	169.44	2.33	2.33	0.42	1.06	0.21	0.00	0.21
ovary, adult, pool1	10020-101D2	140.02	2.36	2.71	1.66	1.31	0.52	0.17	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	157.66	3.12	3.30	2.20	2.20	0.55	0.55	0.18
pancreas, adult, donor1	10049-101G4	64.90	0.94	2.82	0.00	0.00	0.00	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	56.19	0.00	0.84	0.00	0.28	0.84	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	101.19	1.02	1.36	0.00	0.68	0.51	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	174.85	1.49	1.49	1.32	0.99	0.66	0.33	0.99
paracentral gyrus, adult, pool1	10035-101E8	125.93	5.31	1.74	1.83	0.92	0.46	0.18	0.27
parietal cortex, adult, donor10258	10373-105G4	88.81	1.47	0.73	2.94	0.73	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	93.11	4.70	0.94	2.82	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	91.50	2.28	1.14	2.57	2.00	0.29	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	135.62	7.23	1.06	1.23	0.62	0.35	0.53	0.26
parietal lobe, fetal, donor1	10072-101I9	79.53	0.97	0.97	0.00	0.00	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	80.75	1.87	2.24	3.36	3.74	0.37	0.00	0.00
parotid gland, adult	10199-103F1	72.15	1.85	1.23	0.00	1.23	0.00	0.62	0.00
penis, adult	10200-103F2	120.85	2.15	0.54	1.07	1.61	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	84.97	2.23	0.74	0.56	0.74	0.19	0.00	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	82.17	0.44	1.17	0.44	1.31	0.44	0.58	0.29
pineal gland - adult, donor10196	10179-103C8	68.37	2.58	0.65	0.00	1.29	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	121.40	1.18	1.78	0.59	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	84.66	1.88	2.51	1.88	0.00	0.00	0.63	1.25
pituitary gland - adult, donor10196	10180-103C9	104.22	2.02	1.01	0.00	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	153.23	1.04	2.61	0.00	1.04	0.00	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	75.76	0.85	0.00	0.00	0.85	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	226.72	4.30	2.26	1.18	1.29	1.61	0.22	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	101.04	0.53	0.93	0.79	0.40	0.13	1.72	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	209.33	4.36	4.67	1.71	2.96	1.71	1.25	0.00
pons, adult, pool1	10033-101E6	139.17	6.54	1.98	1.12	1.20	0.26	0.34	0.09
postcentral gyrus, adult, pool1	10032-101E5	102.43	5.58	2.18	0.87	1.05	0.09	0.17	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	20.91	0.00	2.09	4.18	0.00	0.00	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	132.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	144.35	2.18	0.87	0.73	0.87	0.87	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	167.71	2.54	2.54	0.73	0.54	0.36	0.73	0.18
prostate, adult, pool1	10022-101D4	140.57	2.90	1.81	1.54	1.63	0.73	0.27	0.45
putamen, adult, donor10196	10176-103C5	135.26	7.32	1.89	6.37	1.42	0.00	0.00	0.94
putamen, adult, donor10252	10152-102I8	121.56	3.92	3.92	3.92	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	74.31	2.19	1.09	7.65	5.46	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	100.03	4.83	3.62	3.14	3.38	0.24	1.21	0.72
putamen, newborn, donor10223	10365-105F5	218.90	6.00	0.00	2.25	3.00	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	75.06	0.58	0.00	0.00	0.00	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	48.68	0.00	0.00	0.00	2.78	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	179.56	3.39	0.64	0.64	0.42	0.21	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	79.94	2.07	0.83	0.00	0.83	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	130.31	2.88	1.69	1.29	1.39	0.70	0.40	0.30
retinoblastoma cell line:Y79	10475-106I7	66.77	1.82	1.04	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	121.35	1.35	1.23	0.86	0.86	0.25	0.25	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	93.64	2.25	1.41	0.56	0.28	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	79.57	0.00	0.00	1.52	1.52	0.00	0.00	1.52
salivary acinar cells, donor1	11771-123I7	111.03	0.81	1.94	0.65	0.65	0.32	0.00	0.49
salivary acinar cells, donor2	11772-123I8	77.93	1.51	1.65	1.24	0.55	0.28	0.28	0.41
salivary acinar cells, donor3	11773-123I9	47.01	1.32	0.00	1.32	1.32	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	106.96	2.86	1.14	0.00	0.00	0.00	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	257.74	3.12	1.85	1.35	0.67	0.93	0.84	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	281.65	3.41	2.94	1.76	1.18	0.82	0.94	0.35
seminal vesicle, adult	10201-103F3	84.12	1.06	1.06	0.00	0.00	0.53	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	105.92	1.21	1.21	1.46	1.46	1.21	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	128.58	3.52	1.26	0.50	1.51	1.01	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	172.61	5.02	1.00	1.00	4.01	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	79.11	2.15	0.67	1.07	0.67	0.40	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	145.23	2.43	1.44	0.66	0.88	0.11	0.11	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	94.83	0.77	0.77	0.00	0.39	1.16	0.52	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	33.34	0.71	0.00	2.13	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	66.81	1.08	0.48	0.60	0.72	0.00	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	22.11	4.02	3.02	1.01	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	67.85	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	91.53	1.89	1.26	0.63	1.26	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	893.84	14.01	8.67	3.67	1.00	1.33	8.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	52.01	0.63	0.00	0.00	0.32	0.00	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	152.27	3.85	2.51	1.16	0.39	0.39	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	82.74	0.66	0.33	0.33	0.16	0.00	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	108.57	3.06	1.77	0.64	0.48	0.00	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	133.15	5.45	2.18	1.31	1.53	0.65	0.00	0.00
small intestine, adult, pool1	10024-101D6	239.12	5.02	3.58	0.84	1.31	4.18	1.19	1.19
small intestine, fetal, donor1	10064-101I1	104.18	1.72	0.74	0.74	0.49	1.47	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	77.96	1.03	1.03	1.54	2.56	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	132.07	3.10	2.33	0.26	1.81	0.26	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	84.96	1.07	1.34	0.80	1.07	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	79.60	3.67	1.84	1.15	0.92	0.00	0.23	0.46
spinal cord, adult, donor10252	10159-103A6	155.34	4.73	4.73	1.97	2.76	0.00	0.00	1.18
spinal cord, adult, donor10258	10369-105F9	137.67	5.53	0.69	1.38	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	89.04	3.66	3.05	1.83	0.61	0.61	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	164.40	3.67	2.76	1.84	2.30	0.92	0.00	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	236.73	1.49	2.99	1.64	1.34	1.49	0.75	0.15
spleen, adult, pool1	10025-101D7	247.25	4.30	2.09	3.08	2.75	2.20	3.52	0.77
spleen, fetal, pool1	10044-101F8	186.08	2.78	3.26	2.38	2.70	0.79	1.35	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	118.94	0.52	0.31	0.10	0.21	0.21	0.41	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	75.19	0.57	0.38	0.19	0.19	0.57	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	69.19	1.05	0.35	0.35	0.00	1.05	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	203.68	0.78	2.74	1.95	3.13	0.39	1.17	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	137.10	3.49	2.48	2.25	2.70	0.23	0.11	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	52.10	1.69	0.85	0.42	0.42	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	120.15	0.42	0.85	0.00	0.42	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	86.51	3.20	5.34	0.00	2.14	1.07	0.00	1.07
submaxillary gland, adult	10202-103F4	78.05	1.14	1.14	2.28	0.57	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	149.96	2.91	4.15	2.49	1.66	0.21	0.42	0.42
substantia nigra, adult, donor10258	10371-105G2	65.69	3.62	1.03	1.03	1.55	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	59.35	0.00	0.00	3.53	1.41	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	97.44	2.98	0.69	0.23	0.23	0.46	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	102.06	4.92	2.03	1.02	0.85	0.42	0.17	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	56.98	1.42	0.00	1.42	0.00	0.00	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	78.24	1.76	0.44	0.44	0.44	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	162.33	4.19	1.75	1.05	1.05	0.35	0.35	0.00
tenocyte, donor2	11765-123I1	88.51	1.91	0.38	1.53	0.38	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	142.34	2.59	2.59	0.37	1.85	0.74	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	253.75	1.36	1.87	0.51	1.02	0.00	0.85	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	101.12	0.92	0.77	0.62	0.46	0.00	0.15	0.31
teratocarcinoma cell line:PA-1	10807-111A6	138.86	0.46	0.77	0.46	0.93	0.15	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	267.73	8.25	4.06	2.03	2.67	1.14	0.51	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	153.92	1.89	1.51	0.38	1.89	1.51	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	242.01	2.29	1.74	0.33	1.74	0.55	0.33	1.42
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	255.68	2.61	3.58	1.63	2.61	0.00	1.95	1.63
testis, adult, pool1	10026-101D8	165.57	3.22	2.25	3.87	1.83	44.88	0.43	3.54
testis, adult, pool2	10096-102C6	105.55	2.26	2.71	7.67	2.26	59.09	0.90	0.00
thalamus - adult, donor10196	10168-103B6	85.01	4.42	0.00	0.00	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	128.15	3.91	2.81	1.41	1.88	0.47	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	53.89	0.00	0.00	0.00	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	50.23	1.32	0.66	1.65	0.66	0.16	0.49	0.49
thalamus, newborn, donor10223	10366-105F6	79.97	1.73	0.00	1.73	1.73	0.00	0.58	0.58
throat, adult	10209-103G2	97.87	1.50	0.75	0.75	1.50	0.25	0.00	0.00
throat, fetal, donor1	10061-101H7	54.85	2.13	0.61	1.22	1.52	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	65.18	0.60	0.40	0.00	0.00	0.20	0.40	0.60
thymus, adult, pool1	10027-101D9	223.48	1.99	1.59	1.29	1.49	0.60	1.49	0.70
thymus, fetal, pool1	10043-101F7	200.33	2.60	1.45	0.94	2.08	0.31	1.66	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	152.11	1.86	0.66	0.66	0.66	0.53	0.80	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	181.74	2.24	1.54	1.26	0.98	0.28	0.42	0.84
thyroid, adult, pool1	10028-101E1	150.23	2.80	2.24	1.40	0.84	0.19	0.37	1.12
thyroid, fetal, donor1	10060-101H6	65.39	1.05	0.79	1.32	1.58	0.26	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	95.82	0.93	0.70	0.93	0.47	0.47	0.00	0.70
tongue, fetal, donor1	10059-101H5	71.33	1.97	1.58	1.18	1.58	0.79	0.39	0.00
tonsil, adult, pool1	10047-101G2	235.41	1.80	2.10	1.40	1.60	1.00	3.91	0.10
trachea, adult, pool1	10029-101E2	175.29	1.80	1.47	0.82	1.15	1.39	0.57	0.65
trachea, fetal, donor1	10058-101H4	65.78	1.54	0.38	1.54	0.38	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	207.96	3.90	2.48	0.00	0.35	0.71	0.71	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	139.41	1.22	0.51	0.30	0.41	0.20	0.71	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	236.44	4.23	0.94	0.63	0.47	0.78	0.16	0.94
tridermal teratoma cell line:HGRT	10694-109G1	66.59	1.90	0.00	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	112.75	1.10	1.27	0.25	0.51	0.85	0.34	0.25
umbilical cord, fetal, donor1	10057-101H3	66.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	209.53	4.78	2.22	2.39	1.37	1.54	0.68	0.17
uterus, fetal, donor1	10055-101H1	88.05	0.51	1.02	0.00	1.54	1.02	0.00	0.00
vagina, adult	10204-103F6	92.41	2.58	0.65	1.29	2.58	0.00	0.00	0.65
vein, adult	10191-103E2	135.25	0.66	2.19	0.66	1.10	0.22	1.10	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	109.75	0.53	0.00	0.27	0.27	0.00	1.07	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000449311.5:66 LF206602:270 MA442179:270 ENST00000421589.5:326 HM005631:326 AK315731:424 ENST00000414893.5:463 ENST00000372792.7:472 ENST00000372805.8:472 NM_001350485.2:472 NM_001105530.2:472 NM_001350483.2:472 NM_001350476.2:472 NM_001350475.2:472 NM_001330502.2:472 NM_006367.4:472 NM_001350482.2:472 NM_001350477.3:472 NM_001350484.2:472 NM_001350478.2:472 AK297829:473 AK300861:473 AK096193:474 ENST00000414281.5:475 ENST00000420216.5:476 AK222513:485 BC095440:486 ENST00000372798.5:495 AK295396:495 AK298110:495 ENST00000340450.7:496 M98474:499" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.